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1 Introduction and aims of the study 
.  
Abomasal displacement (AD) of cattle is a very serious disorder which causes economical 
harm including reduced milk production, the cost of treatment or culling (Doll et al. 2009). 
According to Dirksen (1961) the AD of cattle was observed already in 19th century, but it was 
not until the 1950s that the first cases were published (Begg 1950, Moore et al. 1954, Müller 
1953). Between the years 1948 and 1954 Moore et al. (1954) found 33 cows with AD 
following exploratory laparatomy of 580 cows. Since this initial publication the reporting of 
AD has increased. Coppock (1974) supposed that the increase in reporting of AD was the 
result of new diagnostic techniques and their application, as well as an increase in the 
occurrence of this disorder.  
 
In the meantime, Doll (2007) reported an average lactation incidence of 2.3% in 12 German 
Holstein herds from Hessen, Germany. Other reports from Northern Germany found a 
lactation incidence of 1.6% (Wolf et al. 2001a, b), whereas Poike and Fürll (2000) found a 
lactation incidence of 1.75% with a large variation at herd level of up to 7.5% in some 
individual herds. In North America, a lactation incidence of 3% is considered to be “normal” 
(Whitmore 2004). In some extreme cases it can go up to 20% (Dawson et al. 1992, Pehrson 
and Stengärde 1998). According to Dirksen (2002), changes in cattle breeding and feeding in 
the last decades such as the selection of high milk yield, deep bodied cows and high food 
intake ability are the causes of this enormous increase in the incidence of AD. 
 
The dairy breeds such as German Holstein and Holstein Friesian (Geishauser et al. 1996a, 
Martin et al. 1978, Wolf et al. 2001a, b), Brown Swiss, Ayrshires, Guernseys (Constable et al. 
1992) and Jerseys (Jubb et al. 1991) are affected by AD. Other breeds such as German 
Fleckvieh (Doll 2007), Brown Swiss (Eicher et al. 1999) and Swedish Red Cattle (Stengärde 
and Pearson 2002) also suffer from AD, but the incidence in these breeds is very low 
compared to the classical dairy breeds named above.  
 
There is a variety of risk factors that can lead to AD, but the primary cause of this disease 
remains unknown. It is supposed that hypomotility or atony of the abomasum is a prerequisite 
for the occurrence of AD (Dirksen 1961). This impairment of motility results in the 
accumulation of methane and CO2, which pass into the abomasum from the rumen or are 
produced in the abomasum. The constant accumulation of gases in the abomasum distend it 
like a balloon and cause the abomasum to dislocate either to the left side, where it slides 
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between the abdominal wall and rumen, or caudo-dorsally to the right side. Motility 
impairment of the abomasum is accepted as a prerequisite of AD. Some factors held to be 
responsible for causing this impairment are: metabolic disorders (Holtenius et al. 2000, 
Pravettoni et al. 2004), high-concentrate low-fiber diets (Shaver 1997, Van Winden 2002), 
high insulin concentrations as a result of insulin resistance (Pravettoni et al. 2004) and genetic 
factors (Constable et al.1992, Geishauser et al. 1996a, Wolf 2001).  
 
Geishauser et al. (1998) found an increased activity of neuronal nitric oxide synthase and a 
decreased sensitivity to acetylcholine in the tissue samples from the abomasal wall of German 
Holstein cows with AD compared to healthy cows of this breed (Geishauser et al. 1998). They 
suggested that a dysfunction of enteric neurons may be present in cows with AD. Recent 
studies have focused on possible disorders of the enteric nervous system. However, there are 
very few comparison studies between healthy cows and cows with AD regarding neuronal 
disorders. Furthermore, the immunohistochemical studies on the gastrointestinal tract of 
ruminants are limited (Balemba et al. 1999, Baltazar et al. 1998, Calingasan et al. 1984, 
Guilleteau et al. 1997, Kitamura et al. 1985, Pfannkuche et al. 2002a, b, 2003, Sickinger 2007, 
Soehartono et al. 2002).  
 
Ontsouka et al. (2007, 2010) found with PCR tests that motilin receptor, muscarinic M2, M3 
and α-2A adrenergic receptors were significantly lower in different parts of gastrointestinal 
tract of cows with AD than in healthy cows. Sickinger (2007) found with 
immunohistochemical ABC method that both substance P and vasoactive intestinal 
polypeptide concentrations were lower in cows with AD than in healthy cows. 
 
It is unclear why German Holstein cows have an increased incident of AD when comparing 
them to German Fleckvieh cows. A recent study found significant differences between 
German Holstein and German Fleckvieh cows regarding the content of substance P (SP) and 
total innervation density in the abomasum (Sickinger 2007). The concentration of SP was 
significantly lower in German Holsteins and was accompanied by markedly higher levels of 
the neurotransmitter vasoactive intestinal polypeptide. These differences could explain why 
German Holstein cows are more frequently affected by AD than German Fleckvieh cows.  
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The primary aim of this study is to identify possible factors that may play a role in the 
occurrence of AD concerning the comparatively high incidence of AD in German Holsteins. 
Furthermore, the inter-individual differences between healthy German Holstein individuals 
and those affected by AD are discussed. 
 
The effects of motilin and gastrin on the gastrointestinal motor functions are well known 
(Dockray 1994, Walsch 1994). These substances are hormones within the gastrointestinal 
tract which interact with their receptors to exert their effects. Vasoactive intestinal 
polypeptide (VIP) is a neuropeptide in the gastrointestinal tract which also plays a role in 
abomasal motility. The immunohistochemical expression of receptors for these peptides has 
not been studied in cow abomasum until now. An understanding of physiological functions of 
these gastrointestinal peptides requires precise localization of the peptides and their receptors 
of cattle with AD and healthy cows. Through the comparison of caspase-3 activity and the 
concentrations of motilin-, gastrin- and VIP-receptors and peptides, it was examined if the 
impairment of the abomasal wall has an effect on the abundance of these receptors and 
peptides. For the demonstration of these peptides and their receptors as well as the caspase-3 
activity in the abomasal wall of cattle the immunohistochemical ABC method was used.  
 
In summary, this study aimed to investigate the following questions: 
-  Are there differences between the German Holstein and the German Fleckvieh breed 
regarding the abundance of gastrin and motilin peptides, their receptors and also vasoactive 
intestinal polypeptide receptors in the abomasal wall?  
- Are there differences between healthy German Holstein cows and German Holstein 
cows with AD regarding the substances that have been mentioned above?  
- Is there an impairment of the abomasal wall in healthy German Holstein cows and 
those with AD? 
- If such differences exist, are these a cause or a result of AD? 
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2 Literature review 
 
2.1 Innervation of the gastrointestinal tract 
 
The autonomic nervous system (also called visceral nervous system), hormones and other 
chemicals control motility and secretion of the digestive system. This system is composed of 
extrinsic (sympathetic and parasympathetic) and intrinsic (enteric) nervous systems (Dockray 
1994).  
 
Normally, the sympathetic and parasympathetic nervous systems act as antagonists 
(Schemann 2010). The sympathetic system activates and prepares the body for muscular 
activity, stress and emergencies while the parasympathetic system lowers the activity and is 
active in the normal situations. Sympathetic and parasympathetic neurons are composed of 
two neuron chains. Central parts of the autonomic nervous system are located in the spinal 
cord and brainstem, whereas the peripheral neurons are located in the ganglia outside of the 
central nervous system. The neurons which are located at the spinal cord and brainstem are 
called as preganglionic neurons, whereas the neurons in the ganglia are called as 
postganglionic neurons. The preganglionic neurons of sympathetic nervous system are located 
in the lateral horn of spinal cord and the preganglionic neurons of parasympathetic nervous 
system are located in brainstem and sacral spinal cord (Diener 2010). The neurons of both 
sympathetic and parasympathetic nervous systems use acetylcholine (ACh) as transmitter 
between preganglionic and postganglionic neurons. ACh binds to nicotinergic receptors in the 
postganglionic neurons. The transmission between the postganglionic neurons and the target 
organ occurs differently between both systems. Here, ACh acts as a transmitter in 
parasympathetic system, whereas noradrenaline is the transmitter in sympathetic system. 
Binding of noradrenaline to α-2 and β-2 receptors leads to the inhibition of motility while the 
binding of ACh to muscarinic M-3 receptors leads to motility stimulation (Diener 2010). In 
cows, M-2 and M-3 muscarinic receptors were found to be the most abundant of five 
muscarinic receptor subtypes in the gastrointestinal tract (Ontsouka et al. 2007). However, the 
use of muscarinic antagonists suggests that M-3 receptors play a more important role in 
smooth muscle contraction in cows (Niederberger et al. 2010). There are also co-transmitters 
such as nitric oxide (NO) and neuropeptides, which are released from the neurons of 
autonomic nervous system in addition to classical neurotransmitters ACh and noradrenalin 
(Diener 2010).  
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2.1.1 Extrinsic nervous system 
2.1.1.1 Parasympathetic nerves 
 
In ruminants, the motility of reticulum, rumen and omasum is highly dependent on 
parasympathetic activation. There are few thousand efferent fibers of the vagus nerve in the 
gastrointestinal tract. Therefore, N. vagus uses the enteric nerves as an intermediate amplifier 
(Schemann 2010). The motility of the gastrointestinal tract is controlled reflexive through the 
stimulation of digesta and afferent fibers of the vagus nerve in the medulla oblongata 
(Hofmann and Schnorr 1982). The activation of N. vagus leads to an increased secretion in 
the gastrointestinal tract and both to stimulation and inhibition of muscle activity. The 
activation of muscle cells occurs via muscarinic receptors, whereas the inhibition occurs with 
the release of nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) from the enteric 
nerves (Schemann 2010).  
2.1.1.2 Sympathetic nerves 
 
The sympathetic nerves do not exert their effects on gastrointestinal muscle and mucosal 
activity directly but they use the enteric nerves. They exert their effect directly only on the 
blood vessels. The release of noradrenaline from the sympathetic nerves such as N. 
sympathicus causes an inhibition both on the motility, and the secretion of gastrointestinal 
tract (Schemann 2010). The visceroafferent nerves of the sympathetic nervous system are 
known as “pain nerves”. Certain spinal cord segments are responsible for the innervation of 
certain areas in the body. Therefore, pain from the inner organs is transferred to the certain 
skin areas which are also called as “head zone” (Diener 2010).   
2.1.2 Enteric nervous system 
 
The enteric nervous system (ENS) is responsible for the autonomic regulation of primary 
gastrointestinal tract functions. It is composed of nerve nets which are located in the organ 
walls and it has numerous small ganglia distributed from oesophagus to anus in the 
gastrointestinal tract (Schemann 2010). The main components of enteric nervous system are 
myenteric and submucosal plexuses which are embedded in the gastrointestinal wall. 
Myenteric plexuses are located between circular and longitudinal layers of muscle in the 
gastrointestinal wall and they play a role in the control of gastrointestinal motility. 
Submucosal plexuses are located in the submucosa and they regulate different mucosa 
functions such as secretion and resorption (Diener 2010, Phillips and Wingate 2002).   
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The ENS can activate the muscle and mucosa discretely and regulate motility, secretion, 
microcirculation, and immune processes in the gastrointestinal tract. In the ENS, there are 
three types of functionally different neurons for the regulation of complex processes which 
are: sensory neurons, motor neurons, and interneurons. The sensory neurons are the primary 
afferent neurons of ENS which respond to mechanical, thermal, osmotic, and chemical 
stimuli. Interneurons are responsible for the communication between enteric neurons, whereas 
the motor neurons control gastrointestinal motility and secretion (Schemann 2010). The 
sympathetic and parasympathetic nerves are connected with the ganglia of ENS and their 
effects on the innervation of muscle and mucosal activity occur via the ENS (Philips and 
Wingate 2002). Central nervous system (CNS) is also involved in digesting processes. The 
interaction between the brain and ENS occurs via visceral afferent neurons which conduct 
sensory impulses to the CNS, the sympathetic and parasympathetic nerves are the efferent 
side, which transfers the signals from CNS to gastrointestinal tract (Schemann 2010).  
 
The activities of both excitatory and inhibitory neurons that innervate the muscle are 
controlled by the neurotransmitters in the ENS. In addition to the classical neurotransmitter 
ACh and noradrenaline, the release of neuropeptides such as substance P stimulates the 
motility of gastrointestinal tract, whereas vasoactive intestinal polypeptide (VIP) inhibits the 
GI motility. These effects of the neuropeptides occur without participation of ACh and 
noradrenaline, therefore these neuropeptides are called as non-adrenergic non-cholinergic 
(NANC) transmitters (Schemann 2010). 
 
2.2 Neuropeptides and gastrointestinal hormones  
 
Neuropeptides ranging in size from 3 to 40 amino acid residues constitute a major group of 
intercellular agents for cell to cell communication, either as messenger hormones or as 
neurotransmitters and neuromodulators. They are expressed and released by neurons and 
mediate neuronal communication by acting on cell surface receptors. As they form an 
extremely large class of communicating molecules, it has been shown that the same 
neuropeptide may act at one site as a neurotransmitter, at another site as a neuromodulator, 
and at a third site as a neurohormone (Strand 1999). Some of these peptides can have a 
function both as hormone and transmitter (Dockray 1994). The classical neurotransmitters are 
synthesized in the nerve terminals, with the necessary enzymes being transported from the 
cell body to the terminals. It has been shown that two or more potential transmitters can co-
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localize in the same neuron (Pfannkuche et al. 2002a, Vittoria et al. 2000). They are released 
by nerve stimulation, with the release being dependent on calcium influx. In the 
gastrointestinal tract, neurotransmitters are involved in controlling the motility, secretion and 
absorption (Strand 1999). 
 
The effect mechanism of neuropeptides and gastrointestinal hormones occurs through binding 
of these peptides with their cell surface receptors. Gastrointestinal hormones are molecules 
which transmit information from one cell to another. They are secreted from endocrine cells 
upon stimulation into the bloodstream and are distributed to their targets through the general 
circulation where they elicit an acute response such as secretion or muscle contraction 
(Dockray 1994, Rehfeld 1998). Furthermore, gastrointestinal hormones may act as 
neurotransmitters, local growth factors, and fertility factors (Rehfeld 1998).  
 
2.3 Gastrointestinal peptides  
 
2.3.1 Gastrin 
 
Gastrin was first discovered in antral mucosal extracts of the stomach by Edkins in 1905 as a 
substance, which stimulates the gastric acid secretion (Edkins 1905). 60 years later, Gregory 
and Tracy showed the precise identity of gastrin, they first chemically described the gastrins 
as 17 and 34 amino acid residues, C-terminally amidated peptides (G17, G34) (Dockray 2004, 
Gregory and Tracy 1964). These both G17 and G34 peptides are called as “classical gastrins” 
because they possess the defining biological property of the hormone: the stimulation of 
gastric acid secretion (Dockray et al. 2005, Gregory and Tracy 1964).  
 
Gastrin and cholecystokinin (CCK) share a common C-terminal tetrapeptide sequence, which 
also constitutes the minimal structure essential for biological activity (Johnsen 1998). They 
together constitute the CCK/gastrin family which are the only members of this family in 
mammals (Dockray 2004, Johnsen 1998). Gastrin and CCK are thought to have evolved from 
a common ancestral gene because of their structural and functional similarities (Schulkes and 
Baldwin 1997). Gastrin and CCK can both bind to gastrin/CCK-B receptors, whereas the 
CCK-A receptors bind only sulphated CCK peptides (Rehfeld et al. 2007).  
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The antral G cells are the main site of gastrin synthesis. The distribution of these cells differs 
among species. In humans and dogs, they are localized between the neck and base of the 
antral glands, whereas in rats they are localized on the base of the glands (Walsh 1994). Early 
immunohistochemical studies on ruminant abomasal tissues have also shown a restricted 
localization of gastrin to the antral mucosa of the abomasum and to some extent in duodenum 
but not within the corpus (Baltazar et al. 1998, Calingasan et al. 1984, Kitamura et al. 1985). 
There are different factors which cause gastrin release such as gastric luminal amino acids, 
neuronal stimulation, circulating catecholamines, and gastrin releasing peptide (GRP) and 
inhibited by low gastric luminal pH, by several peptides such as somatostatin, VIP, and by 
certain prostaglandins (Walsh 1994). VIP does not have a direct effect on G cells to stimulate 
gastrin secretion but it stimulates somatostatin release from D cells, which inhibits gastrin 
secretion (Schubert and Makhlouf 1992). When acid secretion is reduced or absent, for 
example as a result of a pernicious anaemia, gastrin release will increase (Jensen 2002).  
 
There are also other cell types than G cells which also release gastrin peptides. But these cells 
contribute only little to circulating gastrin because the secretion seems to serve local purposes 
(Rehfeld et al. 2007). These cells, which express progastrin, could be detected in ileum and 
colon (Friis-Hansen and Rehfeld 1994, Lüttichau et al. 1993), in cerebellar and vagal neurons 
(Rehfeld 1991, Uvnäs-Wallensten et al. 1977) and in the pancreas (Bardram et al. 1990).  
 
The main circulating forms of gastrin in the plasma of most mammals are G34 and G17 
(Walsh 1994). In cats, only gastrin-17 can be detected in the peripheral blood (Rehfeld et al. 
2007). The concentration of gastrin in plasma varies between 10-20 pmol/l in basal state and 
increases to 50 pmol/l after stimulation with a protein rich meal in 15-20 minutes (Rehfeld et 
al. 2007).  However, the concentration of CCK in human plasma is 10 to 20 fold below those 
of gastrin (Rehfeld 1998). Receptor selection is influenced from this difference because the 
10-20 folds lower CCK concentrations in plasma can not compete with gastrin, therefore, the 
gastrin/CCK-B receptors in periphery are the receptors only for gastrin (Rehfeld et al. 2007).  
 
The gastrin receptor 
 
Peptides of gastrin/CCK family bind at the well characterized CCK1 (also known as CCK-A) 
and CCK2 (also known as CCK-B) receptors, which belong to the G protein coupled receptor 
family. These receptors have seven transmembrane segments and in humans 50% of the 
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amino acids are identical (Shulkes and Baldwin 1997). The purification and cloning of these 
receptors made it evident that, these two peptides exert their effects on their target cells by 
binding to their receptors (Kopin et al. 1992, Wank et al. 1992).   
 
Gastrin has a high affinity for CCK2 receptor but not CCK1 receptor, whereas CCK has a 
high affinity for both CCK1 and CCK2 receptors (Noble et al. 1999). CCK1 receptor has been 
first described by Sankaran et al. (1980) in rat pancreas, whereas the CCK2 receptor was first 
found in brain (Innis et al. 1980).  
 
Both gastrin and CCK are secreted from peptide producing cells into the interstitial fluid as 
well as in the blood. From circulating blood, they may specifically act on their target cells 
(Walsh 1994). Both CCK1 and gastrin/CCK2 receptors use the same signalling mechanisms 
to control the secretion. When the CCK2 receptor binds to a G protein, the activation of 
phospholipase C (PLC) occurs as a result, which catalyzes the formation of inositol- 1,4,5- 
triphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates the release of intracellular 
calcium, and DAG activates protein kinase C (PKC) (Sawada and Dickinson 1997).  
 
CCK1 and CCK2 receptor expression was found on multiple tissues but the tissue distribution 
shows a variation between species. In human, gastrin/CCK2 expression was found in the 
parietal and ECL cells of stomach (Kulaksiz et al. 2000, Schmitz et al. 2001, Waldum et al. 
2002), pancreas (Morisset et al. 2003, Reubi et al. 2003), smooth muscle of stomach (Reubi et 
al. 1997) and in brain (Monstein et al. 1996). It was also found in canine stomach mucosa, 
circular muscle and myenteric neurons (Mantyh et al. 1994), ECL and D cells, submucosal 
smooth muscle cells (Helander et al. 1997), guinea pig gastric smooth muscle cells (Bishop et 
al. 1995, Boyle et al. 1993, de Weerth et al. 1997) and parietal cells on the gastric mucosa 
(Tarasova et al. 1994, 1996). Other tissues that the expression of gastrin/CCK2 receptor was 
found are rat vagal afferent neurons (Moriarty et al. 1997) and pancreas (Wank et al. 1992).  
 
Studies dealing with ruminants concerning the localization of CCK/gastrin family receptors 
are very limited. Onaga et al. (2008) found in sheep omasal muscle layer a high expression of 
CCK2 and CCK1 receptors. It is shown that calf pancreas express both CCK1 and CCK2 
receptors (Le Drean et al. 1999, Morriset et al. 2003). Guilloteau et al. (1997) found by 
mRNA analysis that both CCK1 and CCK2 receptors are expressed in the central nervous 
system of the calf. An immunocytochemistry study in calf intestinal mucosa showed a co-
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localization of CCK1 and CCK2 receptors with neural fibres (Zabielski et al. 2002). These 
receptors were also examined by mRNA expression on the ventral sac of the rumen and 
fundus of the abomasum from new born calves, 13 weeks old calves and adult cows (1.5-2 
years old). CCK1 receptor expression in the rumen could be detected in 3 week old animals 
but not in 13 week old and adult animals. CCK2 receptor expression in abomasal wall 
decreased gradually from 3 week old to adult animals and in adult animals the expression was 
very weak (Yonekura et al. 2002). 
 
Effects of gastrin 
 
Gastric acid secretion was the first effect of gastrin to be found (Edkins 1905). Stimulation of 
gastric acid secretion is regulated by gastrin directly by stimulating parietal cells and 
indirectly by stimulating the release of histamine from enterochromaffin-like (ECL) cells, 
which then binds to H2 receptors on parietal cells and stimulate the gastric acid secretion 
(Schubert 2007). The release of somatostatin from gastric D cells is also stimulated by gastrin, 
which is a potent inhibitor of gastric acid secretion (Walsh 1994). The exocrine effect of 
gastrin on pancreas tissues of calves (Le Drean et al. 1999) and human (Valenzuela et al. 
1976) has also been shown. 
 
In humans, it has been shown that the duodenal acidification inhibits gastric motility and may 
induce phase III-like complexes in duodenum (Woodtli and Owyang 1995). In another study, 
patients with gastric acid hypersecretion showed a suppression of interdigestive 
gastrointestinal motility (Bortolotti and Barbara 1988). Verkijk et al. (1998) found that 
infusion of gastrin to postprandial plasma levels prolongs the reoccurrence of phase III motor 
activity in both antrum and duodenum and this effect is a result of increased intraluminal 
acidity rather than gastrin itself. A study in canine also showed that intraluminal acidification 
can interrupt gastric emptying (Lin et al. 1990). However, Gielkens et al. (1998) showed that 
acute inhibition of gastric acid secretion in healthy human patients does not affect 
interdigestive antroduodenal motility. 
 
It has already been shown that the cows with left displaced abomasum have a smaller pH 
value in their abomasum compared to the healthy cows (Geishauser et al. 1996, Krey 2005, 
Meermann and Aksoy 1983).  
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There are also reports that gastrin is a trophic/mitogenic peptide for normal and neoplastic 
gastrointestinal cells (Majumdar and Johnson 1982, Watson et al. 1989, Yassin 1999). Higher 
levels of gastrin in the circulation in human and rodents caused hypertrophy of gastric 
mucosa, hyperplasia of parietal and ECL cells, whereas its absence cause reduced numbers of 
parietal and ECL cells (Bordi et al. 1995, Hakanson et al. 1986, Wang and Dockray 1999).  
 
Todisco et al. (2001) have proposed a cellular apoptosis inhibiting function for gastrin which 
induced by serum withdrawal through the activation of gastrin/CCK2 receptor. Another study 
has also shown CCK2 receptors in the regenerative gastric mucosa in the repair zone adjacent 
to the ulcer crater of rats (Schmassmann and Reubi 2000). This result suggests a role for 
gastrin and CCK2 receptor in the wound healing.  There is also another report which suggests 
an antiapoptotic role for gastrin in human oesophagus tissues (Harris et al. 2004).  
 
The effect of gastrin on smooth muscle has also been studied on different species. In dogs, 
increased gastrin secretion elevates caudal oesophageal sphincter pressure, delays gastric 
emptying, and promotes pyloric muscular hypertrophy (Hall et al. 1989). El-Sharkawy and 
Szurszewski studied also canine stomach and found an enhanced mechanical response to 
pentagastrin and they stated that this effect is a direct action on smooth muscle cells (El-
Sharkawy and Szurszewki 1978).  
 
In humans, pentagastrin has been found to stimulate circular muscle cells of corpus region of 
human stomach (Hara 1980) and slower gastric emptying (Jin-Zhang et al. 1996). Another 
study in humans reported that gastrin by itself does not seem to have a major role in human 
antroduodenal motility regulation (Dooley et al. 1984). In rats, gastrin induces also a 
contraction on gastric smooth muscle cells (Wang and Zhou 2000).  A study reported in rats 
without CCK2 receptor an enhanced gastric emptying of a non-nutrient liquid load (Miyasaka 
et al. 2004).  
 
McLeay and Wong (1989) showed on the sheep omasum and abomasum that pentagastrin 
stimulates both muscle layers of body and antral regions of the abomasum. In contrast, 
pentagastrin showed inhibitory effects on reticuloruminal motility. They concluded that this 
stimulating action of pentagastrin on the abomasum conducted by direct effect on the muscle 
and by cholinergic neurons.  
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Although Vlaminck et al. (1986) found no significant differences between serum gastrin 
levels of healthy cows and cows with abomasal displacement, Sen et al. (2002) found that the 
mean plasma gastrin concentration was significantly higher in cows with abomasal 
displacement than in healthy cows.  
 
2.3.2 Motilin 
 
Motilin was first isolated by Brown et al. in 1971 from hog duodenal mucosa and named as 
motilin because of its biological capacity to stimulate motility of digestive organs (Brown 
1971). Two years later, the complete 22 amino acid sequence of motilin was announced 
which was corrected again a year later by Schubert and Brown (Brown 1973, Schubert and 
Brown 1974). The structure of motilin was also identified in other species like the cat 
(Depoortere et al. 1993), man (Dea et al. 1989), sheep (De Clercq et al. 1997), rabbit 
(Banfield et al. 1992), cow (Huang et al. 1999), horse (Huang et al. 1999), canine (Poitras et 
al. 1983), and differences in amino acid sequences have been found. The N-terminal amino 
acid sequence 1-9 of motilin was found to be responsible for the contractile activity of motilin 
(Huang et al. 1999, Poitras et al. 1992).  
 
Motilin was the only representative in its class until the discovery of ghrelin in 1999 (Kojima 
et al. 1999). The identification and characterization of ghrelin and motilin precursors showed 
almost 50% similarity in their amino acid sequences. As a result of this similitude, ghrelin has 
been identified as “motilin related peptide” (Tomasetto et al. 2000).  Now, motilin and ghrelin 
together constitute the newly discovered motilin-ghrelin family (Poitras and Peeters 2008, 
Tomasetto et al. 2000). A recent study of upper human intestine showed that ghrelin and 
motilin are co-secreted from the same endocrine cells (Wierup et al. 2007).  
 
Motilin is produced by duodenojejunal endocrine cells (Walsh 1994). After the discovery of 
motilin, the immunolocalization of motilin secreting cells has been demonstrated in the upper 
small intestine of dog (Smith et al. 1981, Yanaihara et al. 1978), cat (Depoortere et al. 1993), 
rabbit (Satoh et al. 1995), man (Heitz et al. 1978, Helmstädter et al. 1979, Smith et al. 1981), 
monkey (Helmstädter et al. 1979), pig (Agungpriyono et al. 2000), rat (Sakai et al. 1994), and 
in ruminants such as cow (Kitamura et al. 1985), sheep (Calingasan et al. 1984), and 
Philippine Carabao (Baltazar et al. 1998). Some authors could also locate motilin cells in the 
antrum of rabbit (Satoh et al. 1994) and man (Bryant et al. 1983). Recently Xu et al. (2005) 
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could show motilin in the myenteric plexuses of guinea pig where it is co-localized with nitric 
oxide synthase. Other than gastrointestinal tract, motilin immunoreactivity was also detected 
in brain of man and rabbit (Depoortere et al. 1997). Nilaver et al. (1982) detected motilin 
immunoreactivity also in cerebellum purkinje cells of rat, mouse and human. Feng et al. 
(2007) could also locate motilin and motilin receptor in the rat amygdala. In contrast, Bond et 
al. (1988) could not detect any motilin mRNA in the brain. However, recent studies found 
motilin and motilin receptor in the rat and guinea pig brain (Feng et al. 2007, Liu et al. 2005, 
Xu et al. 2001).  
 
Motilin plays an important role in the initiation of phase III of the migrating motor complex 
(MMC) in man (Peeters et al. 1980) and dog (Itoh et al. 1978, Poitras 1984). It is released at 
100 min. intervals during the interdigestive state when no nutrient is present, at least in the 
duodenum and the upper jejunum, and moreover the release of motilin is inhibited by feeding 
in dog (Itoh et al. 1978) and in man (Rees et al. 1982, Boivin et al. 1990). In ruminants, there 
is a continuous inflow of digesta from the forestomachs into the abomasum, therefore 
abomasum is never empty. Because of this condition, it does not exist any interdigestive 
period in the abomasum. Therefore, the emptying of the abomasum and cleaning of intestines 
does not occur simultaneously in ruminants (Ehrlein 2010). MMC of sheep is not abolished 
by feeding like in dogs and man (Ruckebusch 1977).  Ruckebusch (1977) showed that MMC 
is always present in ruminants and can only be seen during the fasting state in dogs and rats. 
The irregular spike activity of MMC begins in the sheep at the pylorus and there is an antral 
inhibition during the periods of duodenal bulb activity. A study in man showed that motilin 
can induce phase III contractions only in antrum (Luiking et al. 2003). In dog, the plasma 
motilin concentrations coincide with the end of phase III contractions in the stomach (Itoh et 
al. 1978) and the presence of nutrient in duodenum strongly suppresses the endogenous 
release of motilin (Mori et al. 1981). Motilin induced contractions can be obtained through 
stimulation of motilin receptors located directly on smooth muscle cells (Miller et al. 2000). 
 
Tanaka et al. (2001) found that the action of motilin in dogs is not mediated via the vagal 
afferent nerve since exogenous motilin still induced a premature gastric MMC in the 
interdigestive state after vagotomy. In humans, the premature phase III contractions induced 
by exogeneous motilin could be blocked by atropine in the antrum but not in duodenum, 
indicating the involvement of muscarinic mediation in human antrum and a non-cholinergic 
pathway in duodenum (Boivin et al. 1997). 
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Motilin receptor 
 
Feighner et al. (1999) identified the orphan G protein-coupled receptor GPR38, originally 
isolated from thyroid gland, as the human motilin receptor. Recently, the motilin receptor has 
also been cloned from other species like rabbit (Dass et al. 2003) and dog (Ohshiro et al. 
2008).  
 
Motilin receptors are mainly found in the gastrointestinal tract, but their exact localization is 
species dependent. Recent studies located motilin receptor mRNA and immunoreactivity in 
human stomach and upper intestine (Takeshita et al. 2006). In the same study, motilin 
receptor mRNA was found on the mucosal and muscle layers of stomach and upper intestine, 
whereas the immunoreactivity of this receptor was found only in the muscle layer and 
myenteric neurons. Another study found motilin receptor immunohistochemical staining 
being strongest in the antrum but they could also show it in colon and ileum muscle layers (ter 
Beek et al. 2008). Miller et al. (2000) has also found that the motilin receptors are in 
maximum concentration in human antrum and they are located in muscle and nerves in the 
antral wall. In rabbits, the highest concentrations of motilin receptor were found in the antrum 
and colon (Miller et al. 2000b, Van Assche et al. 1998). A functional motilin receptor does 
not exist in the gastrointestinal tract of rodents (Aerssens et al. 2004). Outside of the 
gastrointestinal tract, they could also be shown in the central nervous system (Feng et al. 
2007, Liu et al. 2005) and in thyroid (Feighner et al. 1999). Localization studies of motilin 
receptor in ruminants are very scarce. Ontsouka et al. (2007b) found motilin receptor mRNA 
in abomasal wall and upper intestines of cattle.  
 
The amino acid sequence of human motilin receptor was found to be 52 % identical to the 
human receptor for growth hormone secretagogues (Feighner et al. 1999). GPR38/motilin 
receptor was identified as an orphan receptor belonging to growth hormone secretagogue 
receptor (GHR-S) family (Holst et al. 2004). Motilin receptor is a G protein coupled receptor 
(GPCR) and it has an amino terminus located at the extracellular side and a carboxyl terminus 
located at the intracellular side (Feighner et al. 2009). Motilin shows a high affinity to 
receptors on the smooth muscle cells (Huang et al. 2004). There are two signalling pathways 
that mediate Ca²+-dependent and independent contraction by motilin receptors on smooth 
muscle cells. Motilin initiates Gαq – mediated cascade, Ca²+ /calmodulin activation of myosin 
light-chain (MLC) kinase and transient MLC20 phosphorylation, and contraction as well as a 
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sustained Gαq- and Gα13-mediated Rho-A dependent cascade leading to inhibition of MLC 
phosphatase, sustained MLC20 phosphorylation, and contraction (Huang et al. 2004).   
 
GPCRs stimulated by their agonist are susceptible to tachyphylaxis (De Smet et al. 2009). 
After the finding of erythromycin A (EM-A) as a motilin receptor agonist (Peeters et al. 
1989), it became also clinically relevant when it is discovered that EM-A accelerated delayed 
gastric emptying in patients with diabetic gastroparesis (Janssens et al. 1990).  It has also been 
shown in cows that preoperative administration of a single dose erythromycin increases 
abomasal emptying rate (Wittek et al. 2008). However, recently the motilin receptor agonist 
(ABT-229) has failed to improve the gastric emptying and caused a rapid desensitization of 
motilin receptor (Thielemans et al. 2005). It was shown that the stronger desensitization 
properties of ABT-229 are due to a higher degree of internalization and a delayed recycling of 
internalized receptors to plasma membrane (De Smet et al. 2009). Tack and Peeters (2001) 
discussed that motilides with a short half-life such as EM-A may be less likely to induce 
tachyphylaxis. There are also reports that chronic use of erythromycin causes a down 
regulation of motilin receptors (Bologna et al. 1993, Depoortere et al. 1991).  
 
Effects of motilin 
 
After the discovery of motilin, it was shown that the exogenous administration of motilin 
initiates phase III contractions in the stomach which are similar to spontaneously occurring 
phase III contractions in dogs (Itoh et al. 1976) and man (Tomita 2009, Vantrappen et al. 
1979). Itoh et al. (1978) showed also that the phase III contractility is associated with the 
plasma motilin peaks in dogs, and Lee et al. (1983) reported that the immunoneutralization of 
circulating motilin suppresses phase III contractions. It was also shown that motilin and its 
agonist erythromycin-A accelerates gastric emptying in man (Janssens et al. 1990, Urbain et 
al. 1990) and cow (Wittek et al. 2008). Coulie et al. (1998) suggested that the antral motor 
effects of erythromycin-A (EM-A) in humans were mediated via different pathways. A low 
dose of EM-A induced a premature antral activity which was mediated through activation of 
an intrinsic cholinergic pathway, whereas a higher dose produces prolonged antral contractile 
activity which did not require activation of a cholinergic pathway (Coulie et al. 1998). Bouvin 
et al. (1997) showed also the effect of motilin on the antrum and duodenum is exerted through 
different stimulatory pathways in humans. The finding that the effect of motilin on phase III 
activity in dogs was blocked by a 5-hydroxytryptamine-3 (5-HT3) antagonist suggests that the 
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effect of motilin may be mediated via motilin receptors located on 5-HT neurons in the 
medulla (Itoh et al. 1991). 
 
In vitro studies have shown that motilin induces a contractile activity of smooth muscle of 
man (Cuomo et al. 2006, Lüdtke et al. 1989), guinea pig (Harada et al. 1992), dog (Mizumoto 
et al. 1993) and rabbit (Adachi et al. 1981, Moummi et al. 1989). The contractile effects of 
motilin were not antagonized by muscarinic blockade or by administration of tetrodotoxin to 
inhibit Na+-channels which suggest a direct action of motilin on smooth muscle cells. Both 
motilin and EM-A has also a direct excitatory action on circular smooth muscle of left and 
right human colon in vitro (Van Assche et al. 2001). Tanaka et al. (2001) showed that after 
vagotomy in dogs, the premature gastric MMC was still present.  
 
Motilin was also shown to have effect on gallbladder emptying. Intravenous administration of 
EM-A induced a plasma motilin peak followed gallbladder emptying (Fiorucci et al. 1992). 
This effect is blocked by atropine and ondansetron indicating that cholinergic and 
serotonergic mechanisms are involved (Fiorucci et al. 1992, Fiorucci et al. 1993). However, 
Luiking et al. (2002) could not confirm motilin induced gallbladder emptying in healthy 
volunteers. It has also been shown that the intravenous administration of motilin agonists 
increases the motility of lower esophagal sphincter (Chaussade et al. 1994, Korimilli and 
Parkman 2010). 
 
2.3.3 Vasoactive intestinal polypeptide 
 
Vasoactive intestinal polypeptide (VIP) was discovered by Drs. Victor Mutt and Sami Said in 
1970 from porcine intestinal extracts which displays a 28 amino acid sequence (Said and Mutt 
1970). After the isolation and characterization of this peptide in different species, it has been 
shown that VIP is highly conserved between vertebrate species and belongs to the 
secretin/glucagon/pituitary adenlylate cyclase activating peptide (PACAP) family (Carlquist 
et al. 1979, Dimaline et al. 1984, Dockray 1994). This family has structurally related peptides 
which also include several other peptides like growth hormone releasing hormone and peptide 
histidine isoleucin (PHI). PHI shares structural and functional properties with VIP and it was 
shown that it binds preferentially to VIP receptors (Huang and Rorstad 1990, Tatemoto and 
Mutt 1981). Among these members, VIP and PACAP are structurally and functionally the 
most closely related peptides in this family (Lelievre et al. 2007).  
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The largest amounts of neurons containing VIP are found in the gastrointestinal tract of 
mammals (Dockray 1994). VIP is present in the intrinsic neurons of the stomach which 
mainly innervate the smooth muscle layer (Fahrenkrug 1993). Other than digestive tract, it 
could also be found in the brain (Benagiano et al. 2009, Fahrenkrug 1993), central and 
peripheral nervous system (Said and Rosenberg 1976), spinal cord, urinary system (Dockray 
1994), and in the smooth muscles of respiratory system (Lundberg et al. 1984). Studies in 
ruminants located VIP containing neurons in the myenteric neurons in the abomasal wall and 
pancreas of sheep (Arciszewski and Zacharco-Siembida 2007, Arciszewski et al. 2009) but 
not in the endocrine glands of gastroenteropancreatic cells (Calingasan et al. 1984). Recent 
studies could also locate VIP in the nerves in smooth muscle of the abomasal wall of cows 
(Sickinger 2007, Vittoria et al. 2000) and in the smooth muscle of rumen and reticulum of 
lambs (Pfannkuche et al. 2004). Some authors showed that nitric oxide (NO) and VIP are 
colocalized in the myenteric neurons of bovine gut like several other mammalian species 
(Pfannkuche et al. 2003, Vittoria et al. 2000).  
 
VIP in gastric motility is a putative non-adrenergic non-cholinergic (NANC) transmitter of 
the enteric nervous system. Feeding does not affect the systemic plasma concentrations of 
VIP and normally, the systemic plasma concentrations are low (Dockray 1994). Electrical 
stimulation of vagal efferent fibres in the presence of atropin and adrenergic blockers or 
gastric distention induces VIP mediated gastric relaxation (Chayvialle et al. 1980, D’amato et 
al. 1992, Gaginella et al. 1981, Ohta et al. 1990). It was also shown that the release of VIP is 
calcium dependent (Angel et al. 1983). Stimulation of Nervus splanchnicus was shown to 
inhibit vagally provoked release of VIP in the cat via α-adrenergic receptors (Fahrenkrug et 
al. 1978). Edwards et al. (1978) found that stimulation of Nervus vagus in the calf without 
splanchnic nerves causes a rise both in arterial plasma VIP and in the VIP concentration of 
intestinal lymph. Also in dog, it was shown that vagal stimulation causes an increase in VIP 
concentrations of portal and gastrin venous blood and gastric relaxation (Ito et al. 1988, Ohta 
et al. 1990). 
 
VIP receptors 
 
VIP and PACAP share two common G protein-coupled receptors VPAC1 and VPAC2 while 
PACAP has an additional specific receptor PAC1 (Harmar et al. 1998, Laburthe and 
Couvineau 2002). The PAC1 receptor shows lower affinity for VIP, whereas the VPAC1 and 
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VPAC2 receptors exhibit similar affinities for VIP and PACAP (Laburthe and Couvineau 
2002, Schulz et al. 2004).  However, VIP binds to VPAC1 and VPAC2 in peripheral organs 
including gastrointestinal tract of human (Schulz et al. 2004). The relaxation of smooth 
muscle occurs when VIP interacts with its receptors coupled to cAMP- or cGMP- signalling 
pathways. It was also shown that human fundic smooth muscle is affected by the activation of 
cGMP-pathway, whereas the smooth muscle of antrum is affected by the activation of cAMP-
pathway (Severi et al. 2006).  
 
VPAC2 receptor was mainly found in the smooth muscle of gastrointestinal tract of human 
(Schulz et al. 2004), mouse (Harmar et al. 2004), and rabbit (Murthy et al. 1997), whereas the 
VPAC1 receptor was found in mucosa and myenteric neurons throughout the gastrointestinal 
tract of human (Schulz et al. 2004) and mouse (Harmar et al. 2004). Binding of VIP and 
PACAP released from mucosal nerve fibers and neuroendocrine cells to VPAC1 possibly 
regulates the secretion, whereas binding of VIP released from myenteric nerve fibres to the 
VPAC2 receptor in the smooth muscle of gastrointestinal wall probably regulates the motor 
activity (Schulz et al. 2004). Outside of the gastrointestinal tract, VPAC1 and VPAC2 were 
found in urogenital system, lympathic system of mouse, however, VPAC2 receptors were not 
detected in heart and skeletal muscle. The human lung expresses predominantly VPAC1 
receptors, whereas mouse lung express VPAC2 receptors (Busto et al. 2000, Harmar et al. 
2004, Reubi et al. 2000). VPAC2 receptor distribution shows a difference between mouse and 
man (Harmar et al. 2004). The VPAC1 receptor was also found in smooth muscle cells in 
cerebral arteries and arterioles of rat (Fahrenkrug et al. 2000). In ruminants, a study indicates 
the presence of VPAC1 receptor in calf pancreas membranes (Guilloteau et al. 1997, Le 
Meuth et al. 1991).  
 
VPAC1 receptor was expressed predominantly in most frequently occurring human tumors 
(Reubi et al. 2000). Breast cancer tissues in rats also express VPAC1 receptors predominantly 
(Dagar et al. 2001). VPAC2 receptors were only found in the benign leiomyoma (Reubi et al. 
2000).  
 
Effects of VIP 
 
VIP is an important inhibitory non-adrenergic non-cholinergic (NANC) neurotransmitter of 
peripheral neurons. It has a relaxant effect on both vascular and non-vascular smooth muscle 
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and stimulates the secretion from pancreas and intestines (Dockray 1994). An interplay 
between neuronal NO synthase (nNOS) and the peptide neurotransmitter VIP causes the 
relaxation of smooth muscle in gastrointestinal tract. Stimulation of smooth muscle eNOS by 
VIP causes the production of NO (Murthy 2006).  A study suggested also that VIP induce its 
relaxation effect indirectly by stimulating heme oxygenase 2 (HO-2) to form CO, which in 
turn mediates the relaxation (Watkins et al. 2004). In vitro studies have also shown a relaxing 
effect of VIP on smooth muscle preparations of gastrointestinal tract from different species 
including guinea pig, cat, pig, and man (Bitar and Makhlouf 1982, Grider et al. 1985, 
Lundberg et al. 1984) and a vasodilatation effect (Bardrum et al. 1986). However, it was also 
shown that VIP induces an excitatory effect by causing release of ACh in the ileum of guinea 
pigs (Gordon et al. 1990). Exogeneous infusion of VIP was shown to cause a cessation of the 
electromyographic activity of the abomasum in lamb (Reid et al. 1988).  
 
VIP also acts as presecretory neurotransmitter in the gastrointestinal system. Intravenous 
administration of VIP stimulates intestinal secretion (Schwartz et al. 1974). It has also been 
shown that VIP producing tumors may cause increased fluid secretion and diarrhea which is 
particularly evident in the watery diarrhea syndrome (Bloom et al. 1973). The regulation of 
blood flow in intestines and salivary gland may also be mediated by VIP (Dockray 1994). VIP 
may also stimulate somatostatin release from D cells, which in turn inhibits gastric secretion 
(Sawada and Dickinson 1997).  
 
The frequent overexpression of VIP receptors, especially VPAC1 in human tumors suggest 
that VIP may have a growth stimulating effect (Schulz et al. 2004). VIP receptor antagonists 
have been shown to inhibit this growing effect in various tumor models (Maruno et al. 1998, 
Moody et al. 2001).  
 
There are also reports about the antiapoptotic effect of VIP (Gonzales-Rey et al. 2005). VIP 
and PACAP have been shown to inhibit the production of TNF-α, IL-1β, IL-6, NO and 
several pro-inflammatory chemokines (Delgado et al. 2002, Kim et al. 2000). They also 
stimulate the expression of anti-inflammatory factors IL-10 and IL-1Ra and this action is 
mediated by VPAC1 receptor in mouse (Delgado et al. 2003). Vaudry et al. (2000, 2002) 
showed in rat cerebellar granule cells that PACAP exerts a neuroprotective effect and protect 
dopaminergic neurons from oxidative stress-induced apoptosis death by inhibiting caspase-3 
activation. Said and Dickman (2000) also revealed that the reduction in lung injury by VIP 
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was associated with the inhibition of caspase activation which suppress cell death and 
promote cell survival and with the upregulation of bcl-2 anti-apoptotic protein.  
 
2.4 Caspases 
 
Apoptosis is the major form of cell death in the organism (Krammer 2000). It is a complex 
biological process which enables an organism to kill and remove unwanted, old, and injured 
cells during animal development, normal homeostasis, and disease (Jacobson et al. 1997, 
Porter and Jänicke 1999, Thompson 1995). 
 
Early studies on apoptosis have been carried out in nematodes. Mutation analysis identified in 
the nematode “Caenorhabditis elegans” that the genes ced-3 and ced-4 are essential for the 
apoptosis, whereas ced-9 antagonizes their function and prevents cell death (Ellis and Horvitz 
1986). During the development of this nematode 131 of 1090 somatic cells die because of 
apoptosis. These deaths are precisely controlled because in every animal the same cells die 
and each at its own characteristic time (Ellis et al. 1991). Since the recognition that ced-3 has 
sequence identity with the mammalian cysteine protease interleukin 1-β converting enzyme 
(ICE or Caspase-1), a family of 14 related cysteine proteases has been identified (Fan et al. 
2005).  
 
Cysteine-aspartic proteases (Caspase) are a family of cysteine proteases that play essential 
roles in apoptosis and inflammation (Alnemri et al. 1996, Thornberry and Lazebnik 1998). 
Fourteen caspases have been identified so far (caspase 1-14) and they share similarities in 
amino acid sequence, structure, and substrate specificity (Nicholson and Thornberry 1997). 
Caspases are highly conserved through evolution and can be found from humans all the way 
down to insects, nematodes, and hydra (Budihardjo et al. 1999, Cikala et al. 1999, Earnshaw 
et al. 1999). Caspases are synthesized as inactive proenzymes (procaspases) which contain an 
N-terminal peptide together with one large and one small subunit (Cohen 1997). When cells 
undergo apoptosis, these caspases become activated through one or two sequential proteolytic 
events that cleave the single peptide precursor into the large and small fragments that 
constitute the active enzyme (Budihardjo et al. 1999, Thornberry and Lazebnik 1998). 
Caspases can be classified into two main groups according to the length of their N-terminal 
prodomain. Procaspases such as procaspase-2, -8, -9, and -10 are characterized by their long 
prodomain. These enzymes are responsible for initiating caspase activation cascades. 
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Procaspases with a short prodomain such as procaspase-3, -6, and -7 are called as effector 
caspases. These caspases are the main effectors of apoptotic cell death by cleaving cellular 
substrates, in other words, they are thought to be responsible for the actual demolition of the 
cell during apoptosis (Launay et al. 2005). The apoptosis is irreversible when the effector 
caspases (caspase 3, 6, 7) exert their proteolytic activity (Thornberry and Lazebnik 1998). 
Caspase-3 is one of the most important members of the family due to its important position in 
the apoptotic processes (Porter and Jänicke 1999).   
 
The initiation of apoptosis may be divided into two phases, an initiation and an execution 
phase. In the initiation phase, caspases become initially active, whereas in the execution phase 
these enzymes act to cause cell death. In mammals, there are two main pathways for caspase 
activation which are called intrinsic (mitochondrion-mediated) and extrinsic (death receptor-
mediated) pathways. Both pathways converge to activate caspases (Logue and Martin 2008).  
 
The extrinsic pathway to caspase activation involves the interaction of death receptor ligands 
such as FasL and tumor necrosis factor-α (TNF-α) with the death receptors. The best 
characterized death receptors are Fas (also called CD95) and tumor necrosis factor 1 (TNF1). 
Additional receptors such as death receptor 3 (DR3), DR4, and DR5 have also been identified 
(Ashkenazi and Dixit 1998). Signalling by CD95 plays an important role in peripheral 
deletion of activated mature T-cells at the end of immune response and killing virus-infected 
or cancer cells by cytotoxic T-cells and by natural killer cells (Nagata 1997). Briefly, after the 
binding of FasL with Fas, the activation of initiator enzyme caspase-8 occurs, which in turn 
triggers a cascade of caspase activation by cleaving and activating other procaspases and the 
active enzymes (caspase-3) mediate the execution phase of apoptosis (Kumar et al. 2005).  
 
The intrinsic pathway of apoptosis is the result of increased mitochondrial permeability and 
release of proapoptotic molecules into the cytoplasm after a wide variety of extracellular and 
intracellular stimuli including hypoxia (Malhotra et al. 2001, Nishimura et al. 2008), ischemia 
and reperfusion injury (Iwata et al. 2002, Rowe et al. 2003, Shah et al. 1997), viral infection 
(Lin et al. 2009), trauma (Newcomb et al. 1999), bacterial toxins (Cherla et al. 2003, Menzies 
and Kourteva 2000), DNA damage (Kiang et al. 2010), and oxidants (Maenpaa et al. 2007). In 
vitro studies have also shown that mechanical stretch may induce apoptosis in myoblasts and 
vascular smooth muscle cells of rat and swine, furthermore, the magnitude and duration of the 
mechanical stretch was important for the rate of apoptosis (Edwards et al. 1999, Liu et al. 
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2010, Su et al. 2006). Effects of mechanical stretch have also been studied on the rat lung 
membrane surface cells and alveolar type II cells in vitro. These studies have shown that 
induction of a lung inflation (30 % increase in the membrane surface area) leads to a 
significant increase in the percentage of apoptotic and necrotic cells (Hammerschmidt et al. 
2004, Raaz et al. 2010). When the permeability of mitochondrial membrane increases, several 
proteins can leak out and activate the caspase cascade, especially cytochrome c. Cytochrome c 
binds to the apoptosis protease activating factor-1 (Apaf-1, ced-4 homologue) in the 
cytoplasm and forms a complex called apoptosome which includes cytochrom c, apaf-1, and 
procaspase-9. This complex is responsible for the activation of caspase-9 (Li et al. 1997). 
Other mitochondrial proteins, such as apoptosis inducing factor (AIF) can also leak out to the 
cytoplasm where they bind to and neutralize various inhibitors of apoptosis, whose normal 
function is to block caspase activation (Kumar et al. 2005). The activation of caspase-9 cause 
further activation of executioner caspases-3 and -7 and results in apoptosis (Li et al. 1997).   
 
B cell lymphoma (Bcl-2) family proteins are also very important in the regulation of 
apoptosis. This family has both pro- and anti-apoptotic effects. They normally reside in the 
mitochondrial membranes and the cytoplasm. Bcl-2 is also homologous to the Caenorhabditis 
elegans protein, ced-9. There are more than 20 proteins in this family. The two main anti-
apoptotic members of this family are bcl-2 and bcl-x (Fan et al. 2005). Overexpression of bcl-
2 or bcl-x blocks cytochrome c release in response to a variety of apoptotic stimuli (Yang et 
al. 1997). However, the proapoptotic members of the family such as Bax (Jürgensmeier et al. 
1998) and Bid (Luo et al. 1998) have been shown to induce cytochrome c release from the 
mitochondria.    
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3 Materials and methods 
 
3.1 Tissue material 
 
As mentioned above, the main purposes of this study are to compare the occurence of gastrin 
and motilin peptides, their receptors as well as VIP receptors in the abomasal wall of German 
Holstein and German Fleckvieh cows regarding the breed and inter-individual disposition.  
 
In order to examine the question why German Holstein cows have a higher disposition to 
abomasal displacement than German Fleckvieh cows, paraffin embedded tissue samples were 
used from corpus abomasi and antrum pylori regions of the abomasum from 20 clinically 
healthy German Holstein and German Fleckvieh cows. 
 
Another purpose of this study was to compare the occurence of these peptides and their 
receptors between the individuals of German Holstein cows in order to examine the inter-
individual disposition in this breed and to clarify if these peptides and receptors play a role in 
the occurrence of abomasal displacement. For this purpose, biopsy samples were examined 
from the corpus abomasi and antrum pylori of the abomasal wall of 20 German Holstein cows 
with left-sided AD.  
 
To clarify if the differences found in the occurence of peptides and/or receptors is a cause or a 
result of AD, tissue samples from 3 healthy German Holstein cows (4, 4.5, 5 years old) were 
examined. During a first laparotomy, biopsy samples from the corpus abomasi and antrum 
pylori of the abomasal wall had been taken. In order to induce an abomasal impaction, a 
variable gastric band had been placed to the proximal part of the pylorus, around the 
abomasum after extracting the biopsy samples and left there for three days (Sickinger 2007). 
After 72 hours, these animals had been operated again and biopsy samples from the corpus 
and pars pylorica of abomasal wall had been extracted.   
 
Details of sample collection, operation techniques, treatment of animals and animal 
experiment approvals have been published (Sickinger 2007).  
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3.2 Fixation of the samples 
 
Fixation and further treatment of tissue samples have been published before (Sickinger 2007). 
 
As positive control tissues for antibodies, calf pancreas and cow duodenum biopsy samples 
were extracted and processed to immunohistochemical staining using the same method as 
Sickinger (2007).   
 
The paraffin embedded biopsy samples were cut 6 µm thick using a microtome for the 
immunohistochemical experiments. After cutting, the tissues were fixed on a microscope slide 
and immunohistochemically stained. For counterstaining, haemotoxylin was used. Finally, the 
tissue samples were covered with glycerinegelatine, a protective substance, in order to protect 
the immunohistochemical reaction of the samples from being weakened due to environmental 
effects. Three samples were taken from both antrum and corpus abomasi of every subject and 
the best maintained sample was used in the immunohistochemical analysis and examination. 
 
Preparation and analysis of samples, as well as capturing digital images of these samples were 
carried out at the Institute for Anatomy, Histology and Embryology of Justus-Liebig- 
University, Giessen. The analysis of sample images was carried out using a half automatic 
analysis software program “AnalySIS®, Olympus” in Clinic for Ruminants and Swine 
(Internal Medicine and Surgery) of Justus-Liebig-University, Giessen. 
 
3.3 Immunohistochemistry 
 
Immunohistochemistry is based on the binding of antibodies to a specific antigen in tissue 
sections. There are two types of detection systems which are called direct and indirect 
methods. The direct method is a one-step process in which the primary antibody is conjugated 
with a label. It is an easy and quick method but lacks sufficient sensitivity for the detection of 
antigens (Ramos-Vara 2005). Therefore, Coons et al. (1955) developed a two step method 
called the indirect method. In the indirect method, the primary antibody is not labeled but a 
secondary antibody which binds to the primary antibody is labeled. In comparison to the 
direct method, the indirect method is more sensitive and the intensity of the reaction is 
increased, which are important advantages (Mulisch 2010, Ramos Vara 2005).   
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There are different indirect methods such as the avidin-biotin methods, peroxidase-
antiperoxidase (PAP) method, and tyramine amplification method. In this study a common 
avidin-biotin method called avidin-biotin-complex (ABC) method was used. Avidin is a large 
glycoprotein with a high affinity for biotin. In this method the secondary antibody is 
biotinylated and the third reagent is a complex of avidin mixed with biotin and an appropriate 
label (Ramos Vara 2005). In this ABC method the primary antibody binds to the epitope and 
is marked by a biotinylated secondary antibody which is produced against the primary 
antibody. Following, an avidin-biotin-peroxidase complex binds to the biotinylated secondary 
antibody. The color reaction will occur after adding a chromogen into this reaction. For this 
study an AEC-substrate-kit was used to give red color reaction (Fig. 1) (Mulisch 2010). 
A
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Figure 1: Schematic illustration of the immunohistochemical ABC method. The abbreviations A, 
Ab, Ag, B and E represent avidin, antibody, antigen, biotin and enzyme respectively. 
 
3.4 Antibodies and controls 
 
The exact definitions of the antibodies used in this study are found in Table 1. The specificity 
of motilin and caspase-3 antibodies has been proven (Kitamura et al. 1985, Townson et al. 
2010). To control the specificity of other antibodies, appropriate blocking peptides for these 
antibodies were incubated with the original motilin and caspase-3 antibodies in room 
temperature for an hour in order to block their binding sites.   
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Both positive and negative control protocols were performed with all antibodies that were 
used in this study. Positive control tissue is a tissue on which the proven staining of the 
antibody was shown before [duodenum (motilin receptor) (Fig. 14), human stomach (gastrin 
and VIP receptors) (Fig 2, 4)]. Abomasal biopsy samples were used as negative control 
tissues where the primary antibody was replaced by a PBS solution.   
 
A negative control was also carried out in order to ensure that these antibodies do not react 
with other antigens. For this, each abomasal tissue slice was left without any primary antibody 
but PBS and received all other components of a regular immunohistochemical ABC method 
(Fig. 3). The antibodies that could not fulfill all these criteria have not been used in this study.     
 
Table 1: Antibodies used in this study 
 
Primary antibody Company Species Dilution 
  
Anti- Gastrin A 0586 polyclonal 
Dakocytomation 
(Denmark) Rabbit 1: 500 
 
Anti- Gastrin receptor-B EB06767 Everest Biotech (Great Britain) Goat 3.5 µg/ml 
 
Anti-Motilin R-1104 Yanaihara Inst. Japan Rabbit 1:8000 
    
Anti-Motilin receptor LS_A134 polyclonal  MBL Int. Corp. (USA) Rabbit 1:1000 
 
VIP receptor 1 LS_A1298 polyclonal MBL Int. Corp. (USA) Rabbit 1:80 
 
VIP receptor 2 ABN-MAB 1821-C100 
monoclonal clone AS 69 
Abnova (USA) Mouse 1:120 
 
Caspase 3 antibody Ab4051 polyclonal Abcam (England) Rabbit 1:75 
    
Secondary antibody       
 
Anti Rabbit 
Vector Laboratories 
(USA) Goat 1:250 
 
Anti Goat  
Dakocytomation 
(Denmark) Rabbit 1:400 
 
Anti Mouse 
 
 
Vector Laboratories 
(USA)  
Horse 1:250 
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Blocking peptide Company    Dilution 
 
Blocking peptide for LS_A134 anti motilin 
receptor (GPR38) 
MBL Int. (USA)  10x centrifuge 
before use 
 
Anti CCKBR blocking peptide 
Everest Biotech 
(England)  10mg/ml 
 
Gastrin peptide Abbiotec  25x 
    
Blocking peptid for LS-A1298 anti VPAC1 MBL Int. (USA)  20x 
 
 
 
 
Figure 2: Positive control staining for VPAC2 receptor in smooth muscle of human stomach. Black arrow 
indicates immunoreactive areas for VPAC2 in the neurons of tunica muscularis of the stomach. 
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Figure 3: Negative control in the tunica muscularis of human stomach for VPAC2 receptor. For the 
negative control, the primary antibody is replaced with phosphate buffered saline (PBS) and the rest of 
the immunohistochemical protocol performed as in the positive control staining. 
 
  
Figure 4: Positive control staining for gastrin peptide in the tunica mucosa of the human stomach. Black 
arrows show the positive staining of gastrin in the antral glands of tunica mucosa. 
 36
        
Figure 5: Blocking of the gastrin peptide antibody in the tunica mucosa of the human stomach. To prove 
the specifity of the gastrin antibody, an incubation of the antibody with a correspondent blocking peptide 
(gastrin) was performed. Due to the fact that the binding areas of gastrin antibody were occupied by 
gastrin blocking peptide, no gastrin staining was observed. 
 
         
Figure 6: Positive control staining for the motilin receptor antibody (GPR38) in tunica mucosa of human 
duodenum. Black arrows indicate IR-positive signals. 
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Figure 7: Motilin receptor antibody blocking with a corresponding peptide. No staining was observed 
after incubating the primary antibody with its corresponding blocking peptide. 
 
 
 
3.5 Immunohistochemical staining protocols for the peptides, receptors and 
caspase activity 
 
The original data specifications for the antibodies that were used in this study can differ in 
these tables concerning their dilution or incubation time. In pre-tests of these antibodies, 
optimal staining dilution and time are adjusted to obtain the best results.   
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Table 2: Immunohistochemical protocol for gastrin 
 
Primary antibody:       Gastrin antibody (A058; rabbit polyclonal; 
                                                    Dakocytomation; Denmark) 
Antibody dilution:                      1:500 
Secondary antibody:                   Goat anti-rabbit (BA-1000, Vector) 
Secondary antibody dilution:     1:250 
Method:                                      Avidin-Biotin-Complex method 
Chromogen:                                AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 5 min Cuvette 
9. Protein blocking 5% goat serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:500) 
30 min Humid chamber at RT 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 40 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 10-12 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl substrate buffer + 3 drops AEC-dilution  
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Table 3: Immunohistochemical protocol for gastrin receptor-B 
 
Primary antibody:       Gastrin receptor-B antibody (EB06767; goat polyclonal; 
                                                    Everest Biotech; England) 
Antibody dilution:                      3.5 mg/ml 
Secondary antibody:                   Goat anti-rabbit (Dakocytomation: Denmark) 
Secondary antibody dilution:     1:400 
Method:                                      Avidin-Biotin-Complex method 
Chromogen:                                AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 15 min Cuvette 
9. Protein blocking 5% rabbit serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS  Overnight Humid chamber at 4C° 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 60 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 60 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 10-15 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl Substrate buffer + 3 drops AEC-dilution  
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Table 4: Immunohistochemical protocol for motilin 
 
Primary antibody:       Motilin antibody (R-1104 rabbit polyclonal;  
    Yanaihara Inst.; Japan) 
Antibody dilution:                      1:8000 
Secondary antibody:                  Goat anti-rabbit (BA-1000, Vector) 
Secondary antibody dilution:     1:250 
Method:                                      Avidin-Biotin-Complex method 
Chromogen:                                AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 5 min Cuvette 
9. Protein Blocking 5% goat serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:8000) 
Overnight Humid chamber at 4C° 
 
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 40 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 10-15 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl Substrate buffer + 3 drops AEC-dilution  
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Table 5: Immunohistochemical protocol for motilin receptor (GPR38) 
 
Primary antibody:      Motilin receptor antibody (LS_A134 rabbit polyclonal;  
   MBL Int; USA) 
Antibody dilution:                     1:1000 
Secondary antibody:                 Goat anti-rabbit (BA-1000, Vector) 
Secondary antibody dilution:    1:250 
Method:                                     Avidin-Biotin-Complex method 
Chromogen:                              AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 15 min Cuvette 
9. Protein blocking 5% goat serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:1000) 
Overnight Humid chamber at 4C° 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 50 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 10 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl substrate buffer + 3 drops AEC-dilution  
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Table 6: Immunohistochemical protocol for VIP-1 receptor 
 
Primary antibody:      VIP receptor-1 antibody (LS_A1298 rabbit polyclonal;  
   MBL Int; USA) 
Antibody dilution:                     1:80 
Secondary antibody:                 Goat anti-rabbit (BA-1000, Vector) 
Secondary antibody dilution:    1:250 
Method:                                     Avidin-Biotin-Complex method 
Chromogen:                               AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 5 min Cuvette 
9. Protein blocking 5% goat serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:80) 
Overnight Humid chamber at 4C° 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 40 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 15 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl substrate buffer + 3 drops AEC-dilution  
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Table 7: Immunohistochemical protocol for VIP-2 receptor 
 
Primary antibody:      VIP receptor-2 antibody (ABN-MAB1821-C100  
    mouse monoclonal; Abnova;USA) 
Antibody dilution:                     1:120 
Secondary antibody:                 Horse anti-mouse (BA-2000, Vector) 
Secondary antibody dilution:    1:250 
Method:                                     Avidin-Biotin-Complex method 
Chromogen:                               AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 10 min Cuvette 
9. Protein blocking 5% horse serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:120) 
Overnight Humid chamber at 4C° 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 40 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 15 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl substrate buffer + 3 drops AEC-dilution  
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Table 8: Immunohistochemical protocol for caspase activity 
 
Primary antibody:                       Caspase-3 antibody (Ab4051 rabbit polyclonal;  
     Abcam, England) 
Antibody dilution:                      1:75 
Secondary antibody:                  Goat anti-rabbit (BA-1000, Vector) 
Secondary antibody dilution:     1:250 
Method:                                      Avidin-Biotin-Complex method 
Chromogen:                                AEC (3-amino-9-ethylcarbazol) 
 
  Step Reagent Time Approach 
1. Deparaffinization Xylol 10 min Rack, RT 
  Xylol 10 min  
  Xylol 10 min  
2. Water removal 100% ethanol 5 min  
  96% ethanol 5 min  
  80% ethanol 5 min  
  70% ethanol 5 min  
  50% ethanol 5 min  
  Distilled water 5 min  
3. Rinse  PBS 5 min  
4. Antigen retrieval Citrat buffer 5 min Microwave 800W 
   10 min Microvawe 485W 
5. Rinse  PBS 5 min Shaker 
6. Blocking 0.3% H2O2 in -18 C° 
methanol 
30 min Cuvette 
7. Rinse  PBS 3x5 min Shaker 
8. Permeabilization PBS/BSA/Triton X 100 5 min Cuvette 
9. Protein Blocking 5% goat serum in PBS 30 min Humid chamber at RT 
10. Incubation Primary antibody in PBS 
(1:75) 
Overnight Humid chamber at 4C° 
     
11. Rinse PBS 3x5 min Shaker 
12. Incubation  Secondary antibody in PBS 40 min Humid chamber at RT 
13. Rinse PBS 3x5 min Shaker 
14. Incubation  ABC-Elite-Kit (Vectastatin) 40 min Humid chamber at RT 
15. Rinse PBS 3x5 min Shaker 
16. Detection AEC (Biologo) 10 min Humid chamber at RT 
17. Rinse Distilled water 3x5 min Shaker 
18. Counterstaining Haemotoxylin 10 sec  
19. Rinse Tap water 10 min Cuvette 
20. Coverslip Glycerinegelatine(Merck)   
 
 
ABC-Kit: 5 ml PBS + 2 drops reagent A + 2 drops reagent B 
AEC-Kit: 900 µl substrate buffer + 3 drops AEC-dilution  
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3.6 Microscopic examination and digital imaging  
 
From every sample and localisation, five visual fields were randomly chosen and images 
taken. In order to have a standardization of these images, every image was randomly taken 
using the same scale of enlargement. Each image has an area of 57117.49 µm² and all five 
images from one animal and one localisation have a total area of 285587.45µm².  
 
The digital capturing of the samples was done in the Institute for Anatomy, Histology and 
Embryology of Veterinary Medicine, Justus-Liebig-University, Giessen.  
 
3.7 Measurement of the immunoreactive staining 
 
The five images that were taken randomly from each animal and each localization were then 
analyzed with the help of the program “AnalySIS®”, a graphics tablet, and a pen designed for 
this graphics tablet. The gastrin peptide and motilin receptor immunoreactive areas were 
encircled with the help of this program and its devices, whereas the VPAC1/VIP-1 receptor 
was counted regarding its abundance in a total area of 57117.49 µm² from one image and 
285587.45 µm² from five images. The cells which show caspase activity were also counted 
and the number of apoptotic cells was compared to the number of unaffected cells.  
 
All the data gathered from the images taken were recorded in an excel diagram. The results 
from the areal measurements were acquired as µm², whereas VPAC1 receptor abundance was 
counted and caspase activity comparison was expressed in percentage.  
 
Immunohistochemical staining protocols for the antibodies and receptors used in this study 
were performed on samples taken from the same sections of the abomasum from each animal. 
Therefore, it was possible to compare these peptides and receptors as well as caspase activity 
with each other.  
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4 Statistical analysis 
 
The statistical analysis of the data was carried out by the working group Biomathematics and 
Data processing of the Veterinary Faculty of Justus-Liebig-University Giessen and the 
statistics program BMDP/Dynamic®, Release 7 was used for the statistical analysis.  
 
The variances of the variables between the groups were compared with each other with 
Levene- Tests and if no significant difference was found, a mean value comparison with t-
Test was performed. If the variances were unsimilar, a t-test with separate variance 
assessment was used whereas at similar variances, a t- test with pooled variance assessment 
was performed. 
 
All the data information of German Fleckvieh, German Holstein and German Holstein with 
abomasal displacement groups was compared at the approximated normal distribution of these 
data. For gastrin peptide, BMDP7D one way analysis of variance with data screening 
regarding the localization antrum was used. For the statistical analysis of other substances, 
BMDP2V program was used for two way analysis of variance with repeated measures 
regarding the localizations antrum and corpus abomasi.  
 
The statistical analysis of three German Holstein cows with experimentally induced abomasal 
impaction group was performed using t-test for independent samples for the comparison of 
this group (n = 3) with the control groups (n = 20). For the comparison between the first and 
second operation samples, in other words samples which were extracted before and after 
placing a gastric band, BMDP2V program was performed for two way analysis of variance 
with repeated measures regarding operation time and localizations.  
 
At the evaluation of the statistical significances, the value p ≤ 0.05 was interpreted as 
statistically significant whereas the value p < 0.001 was interpreted as statistically high 
significant.  
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5 Results 
 
5.1 Results of gastrin immunoreactivity 
 
German Fleckvieh 
Gastrin immunoreactivity was detected on the antral mucosa of the abomasal wall. Gastrin 
immunoreactivity has been shown on antrum mucosa by other authors but not on the corpus 
mucosa of the stomach. However, the corpus abomasi of four German Fleckvieh and four 
German Holstein cows have also shown gastrin immunoreactivity in this study. These 
findings haven’t been included in the evaluation of results.  
The evaluation of the immunoreactive (IR) area of gastrin peptide on the antrum of the 
abomasal wall in German Fleckvieh shows a mean value with a standard deviation ( ± s) of 
1175 ± 655 µm². 
 
 
Figure 8: The immunoreactive (IR) staining for gastrin peptide in the antral glands of the abomasum in a 
German Holstein cow. The gastrin IR positive areas are marked with an arrow. 
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German Holstein  
Samples from the antrum of abomasal wall from German Holstein cows without abomasal 
displacement show a mean value with standard deviation ( ± s) of 1105 ± 930 µm² (Fig. 8). 
 
Comparison of both breeds in respect of the immunoreactive area of gastrin peptide 
There is no significant difference between German Holstein and German Fleckvieh cows on 
the antral mucosa of the abomasal wall regarding IR areas of gastrin peptide (Fig. 9) (p = 0.8).  
 
 
Figure 9: Comparison of the gastrin immunoreactivity in healthy German Fleckvieh (GFV) cows and 
healthy German Holstein (GH) cows. There is no significant difference between GFV and GH cows 
concerning their IR-positive area on the tunica mucosa of the antral abomasal wall (p = 0.8). The upper 
boundries of the boxes represent the mean value () and the horizontal lines represent the standard 
deviation (s), ( ± s). 
 
 
German Holstein with abomasal displacement 
The immunoreactive area of gastrin on the antral mucosa of abomasal wall of German 
Holstein cows with abomasal displacement shows a slightly higher mean value ( ± s) of  
1277 ± 863 µm² in comparison to the healthy German Holstein cows (1105 ± 930 µm²). 
However, this difference is not significant (p = 0.8).  
a
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Comparison of immunoreactive area of gastrin peptide in healthy German Holstein 
cows and German Holstein cows with abomasal displacement 
Although the German Holstein cows with abomasal displacement show a slightly higher mean 
value in comparison to healthy German Holstein cows, this value was found to be not 
significant (p = 0.8).  
 
 
Figure 10: Comparison of the gastrin immunoreactivity in healthy German Holstein (GH) cows and 
German Holstein cows with abomasal displacement (GH with AD). There is no significant difference 
between healthy GH cows and GH with AD concerning their IR-positive area for gastrin on the tunica 
mucosa of the antral abomasal wall (p = 0.8). The upper boundries of the boxes represent the mean value 
() and the horizontal lines represent the standard deviation (s), ( ± s). 
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5.2 Results of gastrin/CCKB receptor immunoreactivity 
Gastrin receptors could not be detected in any layer of neither antrum nor corpus of the 
abomasal wall with the help of immunohistochemical ABC-AEC method (Fig. 13). Positive 
control staining of this antibody was performed on calf pancreas and positive IR staining was 
detected on pancreas acinar cells (Fig. 11). After incubating primary antibody with 
corresponding CCKB receptor peptide, this immunoreactive reaction disappeared which 
proves that the antibody was suitable to detect gastrin/CCKB receptor immunoreactivity in 
bovine tissues (Fig. 12). The biopsy samples of the pancreas were extracted as it is mentioned 
in material and method chapter.  
 
  
Figure 11: Positive immunoreactive (IR) staining of CCK-B receptor in German Holstein calf pancreas 
acinar cells. Gastrin/CCKBR IR-positive stained cells are marked with arrows. 
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Figure 12: After binding the CCK-B receptor antibody with its blocking peptide, no IR positive staining 
was detected in pancreatic acinar cells. 
 
 
Figure 13: Antral tunica muscularis of a German Holstein cow after CCK-B receptor antibody staining. 
There is no staining in any part of the tunica muscularis of antrum pylori. 
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5.3 Results of motilin immunoreactivity 
 
Motilin peptide immunoreactivity could not be detected in any layer of the abomasal wall 
(Fig. 15). It is detected only on the duodenal mucosa of five German Holstein cows (Fig. 14). 
These duodenum samples were collected at a local slaughterhouse and were taken within 20 
minutes after shlaughter. Sample extraction and paraffin embedding was carried out as it is 
mentioned in material and method chapter.  
 
 
 
Figure 14: Motilin peptide IR staining in the duodenal glands of a German Holstein cow. IR positive areas 
were marked with an arrow. 
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Figure 15: It could not be detected any motilin peptide IR staining in the antral smooth muscle of German 
Holstein abomasum. 
 
 
5.4 Results of motilin receptor immunoreactivity 
 
German Fleckvieh 
The immunoreactive staining of motilin receptors could be detected on both, antrum and 
corpus smooth muscle layers of the abomasal wall. In the tunica muscularis of antral part of 
the abomasal wall, a mean value with a standard deviation ( ± s) of 206 ± 57 µm² and in 
corpus 172 ± 69 µm² has been measured (Fig. 16).  
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Figure 16: IR staining of motilin receptor (GPR38) in the antral smooth muscle of abomasal wall. Black 
arrows show IR-positive stained areas.    
 
 
German Holstein 
IR area of motilin receptors in the antrum of the abomasal wall represents a mean value with 
standard deviation ( ± s) of 179 ± 53 µm². In the corpus abomasi, the IR area is measured as 
152 ± 52 µm². 
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Comparison of immunoreactive area of motilin receptors in both breeds 
In this respect, the German Fleckvieh cows have a slightly larger IR area of motilin receptors 
in comparison to the German Holstein cows (Fig. 17). Furthermore, this result was not 
significant (p = 0.11). However, the antral tunica muscularis of the abomasum shows a 
significant larger IR area for motilin receptors in both breeds compared to the corpus             
(p = 0.009) (Fig. 18).  
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Figure 17: Comparison of German Holstein (GH) and German Fleckvieh (GFV) cows concerning the 
motilin receptor (GPR38) immunoreactive area. There is no significant difference between these two 
breeds but a tendency that German Fleckvieh cows have more motilin receptors than German Holstein 
cows (p = 0.11). For each box horizontal line represents the median value and the upper and lower 
boundries represent the 75th and 25th percentiles respectively. Whiskers represent the 10th and 90th 
percentiles and dots represent outlier values. 
 
 
 
p(a) = 0.11 
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Figure 18: The antrum has a significant larger IR area of motilin receptor (GPR38) than corpus in both 
breeds (p = 0.009). The different letters show a significant difference between the antrum and the corpus 
abomasi of both German Fleckvieh and German Holstein cows. The upper boundries of the boxes 
represent the mean value () and the lines represent the standard deviation (s), (± s). 
 
 
German Holstein with abomasal displacement 
In this group, the antrum has a mean value with a standard deviation ( ± s) of 125 ± 55 µm² 
whereas the corpus abomasi has an area of 124 ± 43 µm².  
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Comparison of immunoreactive area of motilin receptors in healthy German Holstein 
cows and German Holstein cows with abomasal displacement 
Concerning this criterion, a significant difference is detected between healthy German 
Holstein cows and German Holstein cows with abomasal displacement (Fig. 19). The German 
Holstein cows with abomasal displacement have a significant smaller mean IR area of motilin 
receptors in comparison to the healthy cows of this breed (p = 0.0029).  
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Figure 19: Comparison of motilin receptor immunoreactive areas in healthy German Holstein cows 
(Control) and German Holstein cows with displaced abomasum (DA). Different letters show a significant 
difference between the DA and control groups both in the antrum and the corpus abomasi (p = 0.0029). 
For each box horizontal line represents the median value and the upper and lower boundries represent 
the 75th and 25th percentiles respectively. Whiskers represent the 10th and 90th percentiles and dots 
represent outlier values. 
 
 
5.5 Results of VPAC2 
 
VPAC2/VIP-2 receptors could not be detected in any layer of abomasal wall with 
immunohistochemical ABC-AEC method. VPAC2 positive IR staining is detected in the 
tunica muscularis of the human stomach which is a positive control tissue for this antibody.  
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5.6 Results of VPAC1 
 
German Fleckvieh 
IR-positive staining for VPAC1/VIP-1 receptor is detected in the tunica muscularis of both 
antrum pylori and corpus abomasa (Fig. 20). Due to the fact that the IR area of VPAC1 
receptors is very small-sized, the number of this receptor is counted within 5 image 
dimensions of total 285587 µm². 
The analysis of vasoactive intestinal polypeptide receptor-1 (VPAC1/VIPR1) revealed in 
German Fleckvieh cows a mean number with a standard deviation of ( ± s) 19 ± 9.8 in 
antrum and a mean number with a standard deviation of 19.2 ± 10.9 in corpus of the abomasal 
wall. 
 
 
Figure 20: IR-positive staining of VPAC1/VIPR1 receptor on the tunica muscularis of the abomasal wall. 
The red stained IR positive areas are marked with arrows. 
 
German Holstein 
In this group, the antrum pylori represent a mean number with a standard deviation ( ± s) of 
17.3 ± 6.5 VPAC1/VIP-1 receptors whereas the corpus abomasi exhibits 17.8 ± 8.1.  
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Comparison of immunoreactive signal number of VPAC1 in both breeds 
There are no significant differences between the healthy German Holstein and healthy 
German Fleckvieh cows regarding the abundance of VPAC1/VIP-1 receptor, neither in 
antrum nor in corpus of the abomasal wall (Fig. 21). 
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Figure 21: No significant differences are detected between these two German Holstein (GH) and German 
Fleckvieh (GFV) breeds concerning IR-positive numbers of VPAC1/VIP-1 receptor in the abomasal 
smooth muscle (p = 0.79). For each box horizontal line represents the median value and the upper and 
lower boundries represent the 75th and 25th percentiles respectively. Whiskers represent the 10th and 90th 
percentiles and dots represent outlier values. 
 
  
German Holstein with abomasal displacement 
The German Holstein cows with abomasal displacement present a mean amount with a 
standard deviation of ( ± s) 23.7 ± 11.7 receptors in the antrum and 26.1 ± 11.1 receptors in 
the corpus of the abomasal wall. 
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Comparison of immunoreactive signal number of VPAC1 in healthy German Holstein 
cows and German Holstein cows with abomasal displacement 
Regarding the comparison of healthy cows and cows with abomasal displacement, both 
antrum and corpus of the abomasal wall from German Holstein cows with abomasal 
displacement show a significant higher number of these receptors compared to the healthy 
German Holstein cows (Fig. 22) (p = 0.0053).  
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Figure 22: Comparison of VPAC1/VIP-1 receptor in healthy German Holstein cows (Control) and 
German Holstein cows with displaced abomasum (DA) regarding IR-positive amount of VPAC1/VIP-1 
receptor in the abomasal wall. Different letters show a significant difference between the DA and control 
groups both in the antrum and the corpus abomasi. For each box horizontal line represents the median 
value and the upper and lower boundries represent the 75th and 25th percentiles respectively. Whiskers 
represent the 10th and 90th percentiles and dots represent outlier values. 
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5.7 Results of caspase activity 
 
German Fleckvieh 
In the analysis of the caspase activity, the stained cell nuclei were first counted and then 
proportioned to the entire cell amount of the preparation. Through this process, a percentage 
of caspase activity showing cells is obtained by comparing the stained cells to the entire cell 
amount of the preperation. The abomasal antrum of German Fleckvieh cows shows a mean IR 
ratio with a standard deviation ( ± s) of 18.5 ± 8.3 % caspase activity, whereas the corpus 
shows 21.1 ± 7.9 %. 
 
 
Figure 23: The apoptotic cells are stained with a red color whereas the healthy cells preserve their own 
blue color. Some of the apoptotic cells are marked with arrows. 
 
German Holstein  
In this group, the antrum pylori shows a mean ratio ( ± s) of 16.9 ± 5.8 % and the corpus 
abomasi shows 21.4 ± 6.5 % caspase activity (Fig. 23). 
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Comparison of immunoreactive ratio of caspase activity in both breeds 
A significant difference in the caspase activity between these German Holstein and German 
Fleckvieh cows could not be demonstrated (Fig. 24). However, in the comparison of antrum 
and corpus localizations, the corpus abomasi shows a high significant caspase activity than 
antrum in both breeds (p < 0.001) (Fig. 25). Furthermore, the ratio of apoptotic cells between 
the corpus and the antrum of the abomasal wall of German Holstein cows is significantly 
higher than German Fleckvieh cows (p = 0.0013) (Fig. 25). 
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Figure 24: Comparison of two breeds concerning the caspase activity. There is no significant difference 
between German Holstein (GH) and German Fleckvieh (GFV) cows concerning the IR-% of apoptotic 
cells (p = 0.79). For each box horizontal line represents the median value and the upper and lower 
boundries represent the 75th and 25th percentiles respectively. Whiskers represent the 10th and 90th 
percentiles and dots represent outlier values. 
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Figure 25: Corpus shows high significant higher % of apoptotic cells than antrum in both breeds              
(p < 0.0001). Furthermore, the ratio of apoptotic cell % between the antrum and corpus of GH cows is 
significantly higher than the ratio of apoptotic cell % between the antrum and corpus of GFV cows          
(p = 0.0013). Different letters show a significant difference between the antrum and the corpus of both 
breeds. The upper boundries of the boxes represent the mean value () and the lines represent the 
standard deviation (s), (± s).  
 
 
German Holstein with abomasal displacement 
German Holstein cows with abomasal displacement show a mean value ( ± s) of caspase 
activity of 26 ± 10.6 % in antrum and 29.4 ± 9.4 % in corpus of the abomasal wall.  
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Comparison of immunoreactive ratio of caspase activity in healthy German Holstein 
cows and German Holstein cows with abomasal displacement 
The German Holstein cows with abomasal displacement present a significant higher mean 
ratio of caspase activity compared to the healthy German Holstein cows (p = 0.002) (Fig. 26). 
The comparison between the localizations also shows a high significant higher caspase 
activity in the corpus than the antrum (p < 0.0001) (Fig. 27). 
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Figure 26: Comparison of healthy GH cows (Control) and GH cows with AD (DA). The percentage of the 
apoptotic cells is significantly higher in GH cows with AD than healthy GH cows. Different letters show a 
significant difference between the DA and control group both in the antrum and the corpus concerning 
the percentage of apoptotic cells. For each box horizontal line represents the median value and the upper 
and lower boundries represent the 75th and 25th percentiles respectively. Whiskers represent the 10th and 
90th percentiles and dots represent outlier values. 
 
 65
 
Figure 27: Corpus abomasi of both groups of cows with (OP) and without AD (GH) have a high 
significantly higher percentage of apoptotic cells compared to the antrum abomasi of these cows. Different 
letters show a significant difference between the antrum and the corpus abomasi of both OP and GH 
groups. The upper boundries of the boxes represent the mean value () and the lines represent the 
standard deviation (s), (± s). 
 
5.8 Results of the experimentally induced abomasal dilatation cows 
 
5.8.1 Results from the first operation, before the application of a gastric band 
 
Gastrin 
The immunohistochemical staining of these three German Holstein cows before placing a 
gastric band, in other words cows without an abomasal dilatation or displacement, shows for 
the IR gastrin peptide staining an average area ( ± s) of 211 ± 175 µm² in the antrum of 
abomasal wall. 
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Motilin receptor 
The antrum of the abomasal wall has an average area ( ± s) of  95 ± 46 µm² whereas the 
corpus has an average area of 101 ± 19 µm², concerning the immunoreactive area of this 
receptor. 
 
VPAC1 receptor 
VPAC1 has a mean number ( ± s) of 13.3 ± 5.1 in antrum and 15.7 ± 5.5 in corpus. 
 
Caspase-3 
Caspase-3 activity, as an indicator of the damage that occurred by the mechanical stretch or 
hypoxia, which is caused by the AD, shows a mean apoptotic cell percentage with a standard 
deviation ( ± s) of 19.3 ± 5.9 % in the antrum and 17.9 ± 7.8 % in the corpus of the abomasal 
wall before placing a gastric band.  
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5.8.2 Results from the second operation, after the application of a gastric band 
 
Gastrin 
The samples which have been extracted after placing the gastric band for 72 hours show a 
mean immunoreactive area ( ± s) of 294 ± 78 µm² for the gastrin peptide. This area is 
slightly larger than the area before inducing an abomasal impaction (Fig. 28). But this 
difference is not significant (p = 0.43). 
 
 
Figure 28: The comparison of the effect of placing a gastric band shows no significant difference before 
(OP1) and after laying this band (OP2), concerning the IR-area of gastrin peptide in the tunica mucosa of 
the antrum of German Holstein cows. The upper boundries of the boxes represent the mean value () and 
the lines represent the standard deviation (s), (± s). 
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Motilin receptor 
The immunoreactive area of the motilin receptor (GPR38) after the experimentally induced 
abomasal dilatation has an average area () of 47 µm² in the antrum and 80 µm² in the corpus. 
Such a decrease in the abundance of motilin receptors in abomasal wall was also observed 
between healthy German Holstein and German Holstein cows with AD (Fig. 19). The same 
tendency can also be seen between the both groups before and after placing a gastric band 
(Fig. 29). However, this decrease in both parts of the abomasum is not significant (p = 0.27).   
  
  
Figure 29: The tendency can be observed that the abomasal impaction (OP2) results in a reduction of the 
IR-positive area of motilin receptors (GPR38). However, this reduction is not significant between the first 
(OP1) and second operations (OP2). The upper boundries of the boxes represent the mean value () and 
the lines represent the standard deviation (s), (± s). 
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VPAC1 receptor  
The number of this receptor changes after placing the gastric band for 72 hours from a mean 
value ( ± s) of 13.3 ± 5.1 to 15.3 ± 3.1 in abomasal antrum and from 15.7 ± 5.5 to 19.7 ± 9.3 
in the corpus of abomasal wall. Here, a significant increase after placing the gastric band for 
72 hours is not observed (p = 0.6) (Fig. 30). 
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Figure 30: There is no significant difference between the first (OP1) and second operation (OP2) 
concerning the IR-positive number of VIP-1 receptor. The upper boundries of the boxes represent the 
mean value () and the lines represent the standard deviation (s), (± s). 
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Caspase-3 
The proportion of the apoptotic cells is increased after the second operation (Fig. 31). In the 
antrum, the mean ratio of the caspase activity becomes 31.4 ± 8.9 % and in the corpus 32.3 ± 
6.4 %. This increase in percentage of the caspase activity is not significant but a tendency can 
be seen in both localizations of the abomasal wall (p = 0.12).  
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Figure 31: The % of caspase activity is higher in the samples from second operation (OP2) than first 
operation (OP1) but this increase is not significant. However, a tendency can be observed that the 
abomasal impaction causes an increase in apoptotic cells in the abomasal wall. The upper boundries of the 
boxes represent the mean value () and the lines represent the standard deviation (s), (± s). 
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5.8.3 Comparison of the results between the healthy German Holstein cows without an 
abomasal displacement and the experimentally induced abomasal impaction group 
before placing a gastric band 
 
Gastrin 
There is not any significant difference but a tendency regarding the immunoreactive area 
between 3 healthy German Holstein cows of the gastric band group, sampled before placing 
the gastric band and the 20 healthy German Holstein cows (p = 0.22) (Fig. 32).  
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Figure 32: Although the mean IR-positive area of gastrin in the gastric band group is smaller than healthy 
GH cows, a significant difference could not be detected probably because of high inter- individual 
variation. The upper boundries of the boxes represent the mean value () and the lines represent the 
standard deviation (s), (± s). 
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Motilin receptor 
In this group, the IR area of motilin receptor in the antrum shows a significant difference 
between the healthy German Holstein cows and gastric band group (p = 0.0056). The corpus 
abomasi has also the same tendency but the difference is not significant (p = 0.10) (Fig. 33).  
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Figure 33: In the antrum, the gastric band group has a significant smaller IR-area of motilin receptor 
(GPR38) compared to the healthy German Holstein (GH) cows (p = 0.006). The same tendency could also 
be observed in corpus abomasi but this difference is not significant (p = 0.1). The upper boundries of the 
boxes represent the mean value () and the lines represent the standard deviation (s), (± s). 
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VPAC1 receptor  
Neither in antrum nor in corpus of the abomasal wall, there are significant differences 
between the 20 healthy German Holstein cows and 3 healthy German Holstein cows from the 
gastric band group regarding the abundance of IR VPAC1/VIP-1 receptor (Antrum p = 0.35, 
Corpus p = 0.71) (Fig. 34). 
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Figure 34: No significant differences are detected between the gastric band group and healthy German 
Holsteins regarding the IR abundance of VPAC1/VIP-1 receptor. The upper boundries of the boxes 
represent the mean value () and the lines represent the standard deviation (s), (± s). 
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Caspase-3 
The comparison between healthy German Holstein cows and gastric band group shows no 
significant difference concerning the caspase activity neither in antrum nor in corpus of the 
abomasal wall (Antrum p = 0.51, Corpus p = 0.42) (Fig. 35).  
 
 
 
Figure 35: There are no significant differences between both groups regarding the percentage of apoptotic 
cells.  The upper boundries of the boxes represent the mean value () and the lines represent the standard 
deviation (s) (± s). 
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5.8.4 Comparison of the results between the German Holstein cows with abomasal 
displacement and the experimentally induced abomasal impaction group after placing a 
gastric band 
 
Gastrin 
There is no significant difference between the German Holstein cows with abomasal 
displacement and experimentally induced abomasal impaction group (p = 0.12) (Fig. 36). 
Similar to the comparison between healthy German Holstein cows and gastric band group (Fig. 
32), the IR-positive area of gastrin peptide is smaller in the experimentally induced abomasal 
impaction group than German Holstein cows with abomasal displacement. High inter-
individual variation or low number of animals in gastric band group could be an explanation for 
this tendency. 
 
  
Figure 36: There is a tendency that the experimentally induced abomasal impaction group has smaller IR-
positive areas of gastrin peptide than German Holstein cows with abomasal displacement (DA). However, 
this difference is not significant. The upper boundries of the boxes represent the mean value () and the 
lines represent the standard deviation (s), (± s). 
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Motilin receptor 
The comparison between 20 German Holstein cows with abomasal displacement (DA) and 3 
German Holstein cows sampled after placing the gastric band for 72 hours shows that the 
antrum of the gastric band group has a highly significant smaller IR area of motilin receptors 
(p < 0.0001 seperate). The corpus of the gastric band group shows also a smaller IR area 
compared to the corpus of German Holstein cows with abomasal displacement but this 
difference is not significant (p = 0.09), however the same tendency could also be observed 
(Fig. 37). 
 
 
Figure 37: A decrease in IR-positive areas of motilin receptor (GPR38) is observed in experimentally 
induced abomasal impaction group (OP2) compared to German Holstein cows with abomasal 
displacement (DA) both in antrum and corpus abomasi. However, in the antrum, gastric band group has a 
significant smaller amount of motilin receptor (p < 0.0001), whereas in corpus there is no statistical 
significance but a tendency is observed (p = 0.09). The different letters show a significant difference 
between the DA and OP2 groups both in the antrum and the corpus. The upper boundries of the boxes 
represent the mean value () and the lines represent the standard deviation (s), (± s). 
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VPAC1 receptor  
Regarding the IR-positive amount of VPAC1 (VIPR1) receptor, it is observed that the antrum 
of experimentally induced abomasal impaction group has a significant smaller amount of 
VPAC1 receptor compared to the German Holstein cows with AD (p = 0.04). However, this 
statistical significant decrease of VPAC1 receptors in the antrum of the experimentally 
induced abomasal impaction group can not be observed in the corpus abomasi between both 
groups (p = 0.36).  
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Figure 38: Antrum of the experimentally induced abomasal impaction group (OP2) has a significant 
smaller amount of VIP-1 receptor compared to German Holstein cows with abomasal displacement (DA) 
(p = 0.04). However, such a difference is not observed in the corpus (p = 0.36). The different letters show a 
significant difference between the DA and OP2 groups. The upper boundries of the boxes represent the  
mean value () and the lines represent the standard deviation (s), (± s). 
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Caspase-3 
There is no significant difference between GH cows with AD and with experimentally 
induced abomasal impaction groups either in the corpus or in the antrum of the abomasal wall 
regarding the percentage of apoptotic cells (Antrum p = 0.42, Corpus p = 0.62) (Fig 39). 
 
 
Figure 39: No significant differences are detected between the localizations and groups with regard to the 
% of caspase activity. The upper boundries of the boxes represent the mean value () and the lines 
represent the standard deviation (s), (± s). 
5.9 Relationship between the receptors and caspase activity 
One of the purposes of this study is to evaluate the relationhip of these peptides and receptors 
with each other and with caspase activity in the abomasal wall.  As the caspase activity is an 
indicator of apoptosis and cell death in tissues, it is reasonable to think that an increase in cell 
death of an organ can cause an effect on peptides and their receptors. It is mentioned in early 
chapters that some of these peptides and receptors may also have pro- or anti- apoptotic 
effects, or they may mediate the effects of other substances. It is also thought that these 
peptides and receptors induce stimulatory (motilin) or inhibitory effects (gastrin, VIP) on the 
abomasal motility. Therefore, a comparison of the relationship of these substances can give 
ideas about their roles in abomasal displacement. 
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5.9.1 Relationship between caspase activity and motilin receptor  
 
As mentioned above, the antrum of both healthy German Holstein and German Fleckvieh 
cows has a significant larger IR area of motilin receptors than corpus abomasi (p = 0.009) 
(Fig. 18). This result is accompanied by a significant higher caspase activity in corpus 
abomasi of these both breeds compared to their antrum (p < 0.0001). Moreover, the 
comparison of caspase activity in the corpus abomasi of both breeds results in a significant 
higher caspase activity in the corpus abomasi of German Holstein cows than German 
Fleckvieh cows (p = 0.0013) (Fig. 25). 
 
Another example to the relationship between caspase activity and motilin receptor abundance 
can be observed between healthy German Holstein cows and German Holstein cows with 
abomasal displacement (Fig. 19). The abundance of motilin receptors are significantly lower 
in GH cows with AD than healthy GH cows (p = 0.0029). However, the caspase activity is 
significantly higher in GH cows with AD than healthy GH cows (p = 0.002) (Fig. 26).  
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Figure 40: An increase in the percentage of apoptotic cells in German Holstein cows with AD (DA) is 
accompanied by a decrease in the IR area of motilin receptors (GPR38) both in antrum and corpus abomasi 
compared to the healthy German Holstein cows (GH). Data expressed in mean () µm² ± standard deviation 
(s) for motilin receptor density and % ± s for caspase activity.  (*) The mean value differs significantly 
between the GH and DA groups (p < 0.05). 
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5.9.2 Relationship between caspase activity and VPAC1/VIP-1 receptor  
 
A significant increase in caspase activity in the German Holstein cows with abomasal 
displacement is accompanied also by a significant increase in VPAC1 receptor. An overview 
of the relationship between the caspase activity and the abundance of VPAC1/VIP-1 receptor 
in healthy German Holstein cows and those with AD is shown in the figure 41.  
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Figure 41: The percentage of the apoptotic cells increase in German Holstein cows with AD (DA) both in 
antrum and corpus abomasi compared to healthy cows (GH). In addition, an increase in amount of 
VPAC1/VIP-1 receptors is also observed. Data expressed in mean () number ± s for the VPAC1 receptor 
and mean % ± s for the caspase activity. (*) The mean value differs significantly between the GH and DA 
groups (p < 0.05). 
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5.9.3 Relationship between VPAC1/VIP-1 receptor and motilin receptor 
 
According to the results of this study, it is observed that the abundance of motilin receptors is 
significantly lower and the abundance of VPAC1 is significantly higher in GH cows with AD 
than in healthy GH cows. An overview of the relationship between the motilin receptor and 
the abundance of VPAC1/VIP-1 receptor in healthy German Holstein cows and those with 
AD is shown in the figure 42. 
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Figure 42: The relationship between the motilin receptor (GPR38) and the VPAC1/VIP-1 receptor is 
opposite between the German Holstein cows with abomasal displacement (DA) and healthy German 
Holstein cows (GH).  Data expressed in mean () number ± s for the VPAC1 receptor and mean µm² ± s 
for the motilin receptor. (*) The mean value differs significantly between the GH and DA groups               
(p < 0.05). 
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6 Discussion 
 
6.1 Discussion of the immunohistochemical ABC method 
 
The present study utilized immunohistochemistry to detect the cellular location and presence 
of motilin, gastrin and their receptors, VIP receptors and caspase-3 activity in the abomasal 
wall of cattle using appropriate antibodies. This technique is based on binding of antibodies to 
a specific antigen and a visualisation of the occurring signal. Immunohistochemistry is an 
important method to detect the localization of tissue proteins and can also be used to 
demonstrate the presence of material that is specific for an infectious organism in animal 
tissues (Mulisch 2010). Complete preparation of the sample is critical to maintain cell 
morphology, tissue architecture, and the antigenicity of target epitopes. Authors have 
described many intrinsic and extrinsic factors which influence immunostaining. Intrinsic 
factors include fixation, duration, type of fixative, temperature, pH of fixative variables in 
tissue processing, antigen loss resulting from delays in fixation, tissue necrosis, and levels of 
antigen expression, whereas extrinsic factors include reagent dilution, detection system and 
chromogen, the method of antigen retrieval, retrieval solution pH, and molarity (Leong 2004, 
Taylor and Levenson 2006). Selection of appropriate antibodies is also one of the most 
important steps of immunohistochemical diagnostic process. Inappropriate antibodies may 
detect non-specific signals from cross-reacting proteins, such as if similar epitopes of different 
antigens are present in the sample (Mulisch 2010). Some of the antibodies used in this study 
were not tested on bovine tissues. Therefore, a positive control tissue staining and blocking of 
these antibodies with corresponding peptides were required. Furthermore, the protein 
sequences of these antibodies were compared with the bovine protein sequences. The 
antibodies which show the highest similarity to bovine sequences were chosen and used in 
immunohistochemical detection. It has been shown that, the antibodies produced for use in 
human tissues for immunohistochemical detection might also be applied in tissues of other 
species (Ruiz et al. 2005). In addition, using these antibodies with negative control sections 
and the absence of positive signals in these sections is also an indicator of specifity.  
 
Another complication lies in the interpretative aspects and the subjective characteristics of 
immunohistochemistry. Interpretation and cut-off values are variables that greatly influence 
results (Leong et al. 2010). The lack of well defined standards of what constitutes a positive 
result and whether there are grades or degrees of positivity are some of the problems 
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encountered in this area. Zlobec et al. (2006) examined the intraobserver reliability among 
four pathologists of immunohistological scores and they found a poor agreement between the 
observers concerning the scoring of different factors. Such findings attest to the poor 
reproducibility when immunohistochemistry is used in a quantitative manner. Despite these 
shortfalls in the formulation of histological diagnoses, there is still a good reproducibility 
between observers for the recognition of many common diagnostic entities (Leong 2010). It 
has been suggested that objectivity can be attained by using image analysis methods. Tadrous 
(2010) proposed that such automated analytical methods are useful for repetitive processes 
such as counting, but repeatability and automaticity must not be confused with objectivity. 
However a lack of objectivity does not imply a lack of utility. Another important aspect of 
image analysis is that, it is achieved through the subjective selection and separation of 
stainings from the background (Leong et al. 2010). Even though enormous innovations in the 
capabilities of image analysis systems have been made, the evaluation of 
immunohistochemical methods can not produce accurate results if the background stain 
suffers from non-specific binding. As the purpose of this study is a quantitative comparison of 
the substances mentioned above, a visual control of the immunoreactive staining in the 
abomasal wall was required.  
 
In this study, the positive immunoreactive areas of gastrin peptide and motilin receptors are 
encircled with the help of the AnalySIS® software program. The immunoreactive area of these 
substances is measured in five visual fields chosen at random in a section for each sample, as 
it is performed by Sickinger (2007). The positive cell staining of caspase-3 is counted and 
compared to the whole amount of cells from five randomly taken image areas as performed by 
Bodie (2006) whereas the mean number of VIP1 receptor staining is counted in a total visual 
area of approximately 0.28 mm² as carried out by Calingasan et al. (1984).  
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6.2 Discussion of immunohistochemical staining results 
 
This study examines the role of the peptides gastrin, motilin, their receptors and VIP receptors 
as potential causes of abomasal motility impairment. The abundance of each of these peptides 
and their receptors was measured using the immunohistochemical ABC method. Following 
Sickinger's research, which has shown evidence of different neuropeptide contents (Substance 
P, VIP) as well as neurofilament 200 in the abomasal wall of German Holstein (GH) and 
German Fleckvieh (GFV) cows, an inter-breed comparison was made between the breeds 
German Holstein and German Fleckvieh; and an intra-breed comparison was made between 
healthy German Holstein cows and German Holstein cows with abomasal displacement (AD).  
 
The role of these examined peptides and receptors in the gastrointestinal motility of ruminant 
species has been studied by various authors (Huang et al. 1999, Mcleay and Wong 1989, Reid 
et al. 1988). Motilin and its receptors are shown to be stimulating factors of gastrointestinal 
motility, whereas VIP, gastrin and their receptors play an inhibiting role. A hypo- or atony of 
the abomasum prior to the abomasal impaction and displacement is hypothesized to be the 
cause of the abomasal displacement. Therefore, it is analyzed if a low abundance of motilin 
and motilin receptors as gastrointestinal motility stimulating factors and/or a high abundance 
of VIP receptors, gastrin and gastrin receptors as gastrointestinal motility inhibiting factors, 
could be a cause of this motility impairment of the abomasum prior to the abomasal 
displacement. 
 
Up to the present, immunohistochemical studies have largely been used to show the presence, 
distribution, and co-localization of the peptides in gastrointestinal tissues of non-ruminant 
species, however the number of the immunohistochemical studies in ruminants are limited 
(Balemba et al. 1999, Baltazar et al. 1998, Calingasan et al. 1984, Guilloteau et al. 1997, 
Kitamura et al. 1985, Myojin et al. 2000, Pfannkuche 2002a, 2002b, 2003, Sickinger 2007, 
Soehartono et al. 2002). Recently, researchers are focusing on the quantitative comparison of 
diverse gastrointestinal hormones and neuropeptides regarding inter- and intra-breed 
abundance of these substances (Geishauser et al. 1998, Ontsouka et al. 2007b, Sickinger 
2007). Sickinger et al. (2008) published a breed comparison study for the first time and found 
that German Fleckvieh cows have significant higher amounts of substance P neuropeptide 
with lower amounts of VIP in the abomasal wall than German Holstein cows. Geishauser et 
al. (1998) and Ontsouka et al. (2007b) performed a quantitative comparison of gastrointestinal 
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motility-mediating substances and receptors between healthy cows and cows with AD and 
found that the cows with abomasal displacement exhibit lower amounts of motility 
stimulating substances accompanied by higher amounts of motility inhibiting substances. 
 
The first aim of this study is to find out if the examined substances could play a role in the 
breed predisposition regarding the occurrence of AD between German Holstein and German 
Fleckvieh breeds, and to examine the difference in the abundance of these substances in 
healthy GH cows and GH cows with AD. For this purpose, gastrin, gastrin/CCKB receptor, 
motilin, motilin receptor, VIP receptors and caspase-3 activity are analyzed in the abomasal 
wall of these two breeds in order to examine if these substances could be a factor in the 
occurrence of AD. 
 
Based on the results of this study, the role of gastrin in the occurrence of AD seems to be 
questionable. There are very few studies which examine the amounts of gastrin peptide 
between healthy GH cows and GH cows with AD. An inter-breed comparison has not yet 
been published. Some studies examined serum gastrin levels between healthy cows and cows 
with AD. Sen et al. (2002) found significantly higher levels of gastrin in cows with AD than 
in healthy cows, whereas Vlaminck (1986) found no significant difference between these two 
groups. In this study, no significant differences are found between healthy cows and cows 
with AD regarding the amounts of gastrin. This result might indicate that gastrin is not 
secreted from antral glands significantly more or less in cows with AD and seems not to be 
involved in the regulation of abomasal motility. Another explanation for the insignificant 
results could be that the variation of the results varies among the individuals greatly. This 
finding supports the results from Vlaminck (1986). Furthermore, concerning the breed 
comparison, no significant differences are found between healthy GH and GFV cows. 
According to this result, it can be suggested that gastrin does not play a role in this breed 
predisposition.     
 
Furthermore, there were no gastrin/CCKB receptors found on the tunica muscularis of the 
abomasal wall using the immunohistochemical ABC method. The published work reviewed in 
this study shows no record of cases examining the immunohistochemical expression of 
gastrin/CCKB receptor in the abomasal wall of cattle. However, Yonekura et al. (2002) 
showed mRNA expression of gastrin/CCKB receptors in young calves and to a very slight 
extent also in adult cows (1.5- 2 years), suggesting that the age and weaning could have an 
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effect on the occurence of these receptors in cows. On the other hand, a very slight amount of 
this receptor was detected in the abomasal wall only after employing 60 cyclic amplitudes of 
PCR. Moreover, the samples taken from the abomasal wall are full thick specimens in 
Yonekura’s study which also includes tunica serosa of the abomasal wall. It is possible that 
they have detected these receptors on the tunica serosa of the abomasum but not on the tunica 
muscularis. Another possibility is that the immunohistochemical ABC method is not able to 
detect very small amounts of this receptor in the abomasal wall. Nevertheless, the absence of 
gastrin receptors in the smooth muscle of the abomasum suggests that gastrin does not exert 
its motility effect directly by reacting with its receptors on the smooth muscle cells of the 
abomasal wall or it has no effect on the abomasal motility. This hypothesis is supported by the 
gastrin polypeptide comparison results of this study, which show no significant differences in 
the amounts of this polypeptide either in inter- or intra-breed comparison.  
 
Motilin peptide immunoreactivity is not detected in any layer of the abomasal wall both in 
healthy cows and cows with AD. This finding is compatible with other immunohistochemical 
studies which were performed in bovine gastrointestinal tract (Kitamura et al. 1985, 
Calingasan et al. 1984). Duodenal biopsy samples from German Holstein cows after slaughter 
were used as positive control tissues for motilin peptide immunoreactivity in this study. 
Motilin immunoreactivity is detected in the duodenal mucosa, but not in the tunica muscularis 
of the duodenum. This result might indicate that the motilin peptide is secreted from duodenal 
glands of the bovine gastrointestinal tract and is transported through the blood circulation to 
its receptors in the abomasal wall, where it binds to its receptors and exerts its motility 
stimulating effects (Walsh 1994).    
 
The motility inhibitory effect of VIP in the gastrointestinal tract of ruminants is already 
known (Reid et al. 1988). This neuropeptide reacts with both VPAC1 and VPAC2 receptors 
with similar affinities (Laburthe and Couvineau 2002, Schulz et al. 2004). The literature 
shows that the VPAC2 receptors are found to be present in the smooth muscle of the stomach 
of many different species (Harmar et al. 2004, Murthy et al. 1997, Schulz et al. 2004) and it is 
made responsible for the direct inhibitory effects of VIP in the smooth muscle. However, in 
this study, these receptors could not be detected in any layer of the abomasal wall using 
immunohistochemical ABC method and interestingly, VPAC1 receptors are detected in small 
amounts in the smooth muscle of abomasum. This result suggests a possible species 
difference between bovine and other species regarding the existence of VIP receptor subtypes 
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in the abomasum of cows and the stomach of human, mouse, and rabbit. Such a species 
difference was also observed between human and mouse lung tissues concerning the 
expression of VIP receptors. Mouse lung expresses predominantly VPAC2 receptors whereas 
human lung expresses predominantly VPAC1 receptors (Busto et al. 2000, Harmar et al. 
2004, Reubi et al. 2000). Moreover, VPAC1 receptors have also been shown on the smooth 
muscle of different tissues such as cerebral arteries and arterioles, pulmonary artery and aortic 
smooth muscle of rat (Fahrenkrug et al. 2000, Hilaire et al. 2010).  
 
It has already been shown that these VPAC1 receptors are widely distributed in human 
carcinoma cells which suggests that these receptors can upregulate themselves in certain 
circumstances (Schulz et al. 2004). The antiapoptotic action of VIP has also been shown in 
different species and this action is mediated by VPAC1 receptors (Delgado et al. 2003, 
Guitterez-Canas et al. 2003). As the apoptotic cell number of the abomasum increases with 
the abomasal displacement, the number of these receptors could also increase in order to exert 
its antiapoptotic actions. This could also be an explanation for the increase in VPAC1 
receptors in this study. Sickinger (2007) found that the abundance of VIP neuropeptide in 
cows with abomasal displacement is lower than in the healthy cows. An overexpansion of the 
abomasal wall could cause impairment on the neuronal structures which could induce a 
disturbance of the transportation of VIP to its receptors on the cell walls. In order to make the 
cells more sensitive to VIP, these receptors may increase their numbers. Valette et al. (1995) 
examined receptor densities in dog hearts after surgical denervation and found an up-
regulation of β-adrenergic receptors following heart denervation.  
 
Studies on the gastrointestinal disturbances of ruminants also suggested the involvement of 
other neuropeptides and receptors such as adrenergic and muscarinic receptors in the 
gastrointestinal motility (Meylan et al. 2004, Ontsouka et al. 2010, Stoffel et al. 2006).  
Ontsouka et al. (2007) found a significantly higher abundance of β-2 adrenergic receptors, 
which cause smooth muscle relaxation, in the duodenum of cows with abomasal displacement 
compared to healthy cows. This result is in accordance with the VPAC1 results of this study 
and suggests an increase of the receptors which mediate impairment of gastrointestinal 
motility in cows with abomasal displacement. However, Ontsouka et al. (2010) also detected 
an increase of M2 receptors (not significantly), which mediate the cholinergic contractile 
signals of ACh, in the abomasal wall of cows with abomasal displacement in comparison to 
the healthy cows. This result is conflicting with the results of this study, since the number of 
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motility stimulating motilin receptors is significantly lower in cows with AD in our study, 
whereas the number of motility inhibiting VPAC1 receptors is higher.  
 
Considering the inter-breed comparison results of this study, the tendency that German 
Fleckvieh cows have more motilin receptors in the abomasal wall than German Holstein cows 
could explain why the incidence of abomasal displacement is lower in these cows than in 
German Holstein cows. Motilin has a gastrointestinal motility stimulating effect and the 
rareness of its receptors in German Holstein cows could be a cause of the decrement in the 
effectiveness of this polypeptide to exert its stimulating effect properly and directly on the 
smooth muscle of the abomasum. VPAC1 receptors show no significant difference between 
both breeds which suggests that stimulatory factors play a major role in this breed difference 
according to the results of this study. These results conform to the results from Sickinger 
(2007), who found a significantly higher motility stimulating neuropeptide SP and a lower 
amount of inhibiting neuropeptide VIP in German Fleckvieh cows, compared to German 
Holstein cows. Between these breeds, no difference is detected in caspase activity which 
shows that there is no difference in impairment levels in the healthy abomasi of these breeds.  
However, both breeds have a marked significantly higher caspase activity in their corpus 
abomasi than in antrum, which is accompanied by significantly higher abundance of motilin 
receptors in antrum of both GH and GFV cows compared to the corpus abomasi. This result 
indicates a correlation between the caspase activity and motilin receptors. If the impairment of 
the abomasal wall increases, which is detected by caspase-3 antibody, the abundance of 
motilin receptors decreases in the abomasal wall of cows.   
 
Regarding the intra-breed comparison, German Holstein cows with abomasal displacement 
show a significant decrease in motilin receptors compared to the healthy cows and this result 
is accompanied by a significant increase in VPAC1 receptors in GH cows with AD. This 
result coincides with the results from Ontsouka’s study who found significant lower motilin 
receptor densities in the duodenum of abomasal displaced cows compared to healthy cows 
(Ontsouka et al. 2007b). A decrease in motilin receptors accompanied by an increase in VIP 
receptors could be a cause of the abomasal motility impairment and ensuing abomasal 
displacement. It is reasonable to hypothesize that, if there are not enough motilin receptors for 
motilin peptides to bind on in the abomasal wall, the motility activating effect of motilin 
could be impaired. However, Wittek et al. (2008) could induce a higher abomasal motility rate 
after abomasal surgery for 4 hours with preoperative (1 hour) administration of 10 mg/kg i.m. 
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erythromycin, which is a motilin receptor agonist. It is possible that the secretion of motilin 
polypeptides from the duodenal endocrine M cells could also decrease in accordance with 
motilin receptors in the abomasal wall and that the administration of 10 mg/kg erythromycin 
can still cover all the expressed motilin receptors and induce its stimulating effect. The 
motilin polypeptide secretion from the duodenal mucosa should be further examined. 
 
Furthermore, a significant increase in caspase activity in cows with displaced abomasi could 
be detected. The already mentioned decrease in the amount of motilin receptors might be 
explained by the increased caspase activity of the abomasal wall in cows with AD. As 
mentioned before, a hypoxia or mechanical stretching of the abomasal wall can trigger 
apoptosis cascades (Rowe et al. 2003). It has already been shown that the oxygen saturation of 
the abomasal wall is lower in cows with abomasal displacement than healthy cows (Wittek 
and Fürll 2003). It is probable that this hypoxia in the displaced abomasal wall is a result of 
the compression of the blood vessels due to the distention of the abomasal wall and the 
torsion of the abomasum itself.   
 
High numbers of apoptotic cells in the displaced abomasum may also be a result of ischemic 
cell injury and subsequent inflammation. Rowe et al. (2003) found in horses with small 
intestine or large colon strangulation, obstruction or distention higher numbers of apoptotic 
cells than healthy horses. The distention of the colon in horses can be compared with the 
abomasal displacement of cows, in which the abomasum also distends. In vitro studies on rat 
lungs also showed that, distention of the rat lung (30% increase in the membrane surface area) 
leads to a significant increase in the percentage of apoptotic and necrotic cells 
(Hammerschmidt et al. 2004, Raaz et al. 2010). Therefore, it can be assumed that the 
distension of the abomasum leads to an increase in caspase activity, which in turn could 
influence the cells stability and the abundance of receptors in the abomasal wall.  
 
Another aim of this study is to clarify, if the observed differences regarding the abundance of 
these gastrin and motilin peptides, their receptors and VIP receptors are a cause or a 
consequence of abomasal displacement. The evaluation of hitherto existing results suggests 
that the changes in the amounts of the examined substances are a consequence of the 
abomasal displacement rather than being a cause of it. Although the occurence of the 
examined substances show no significant differences before and after placing a gastric band, 
the tendency of the amounts of gastrin, motilin receptors, VIP receptors, and caspase-3 
 90
changed in the same manner as seen between the healthy cows and cows with AD. This 
indicates that, a decrease or an increase in the amounts of these substances could be caused 
artificially by placing a gastric band. Therefore, these changes in the amounts of these 
substances appear to be a consequence of abomasal displacement.  
 
The low number of cows with experimentally induced abomasal impaction and the variation 
of the results among the cows of this group could be a cause for the insignificant results.  In 
addition, if the existence of the gastric band and the passage disturbance in the abomasum 
would have been prolonged, this could potentially cause marked differences in the existing 
results as the gastric band induces a mechanical stress and pressure on the abomasal wall. 
Therefore, it could be concluded that these changes in the abundance of these substances are a 
consequence of AD.   
 
It is known that after the abdominal surgery and mechanical stimulation of the gastrointestinal 
system, a panenteric atony takes place which is called a postoperative ileus (Bauer 2010). The 
involvement of different receptors, peptides and immune components were made responsible 
for causing this disorder. De Winter et al. (1998) suggested the involvement of VPAC1 
receptors, NO and VIP in the pathogenesis of postoperative ileus in rats. For that reason, it is 
possible that the changes in the abundance of examined substances in this study could be a 
result of the abdominal surgery itself. To clarify this effect, further investigations will be 
necessary. 
 
In this study, the sampling technique (slaughter vs. OP) does not have any influence on the 
amounts of apoptotic cells, gastrin peptide and VPAC1 receptor, whereas the amounts of 
motilin receptors are significantly lower in the antral wall of the abomasum in cows operated 
to place a gastric band. The same tendency could also be seen in the corpus but this result is 
not significant. The comparison of cows with AD and cows with experimentally induced 
abomasal impaction shows that there is a significant effect of the gastric band on the amounts 
of motilin receptors. This result is in accordance with the results from studies which show that 
the use of erythromycin in human patients with postoperative ileus does not resolve post 
operative ileus in these patients (Bonacini et al. 1993, Smith et al. 2000).  
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This finding suggests that motilin receptors might be more sensitive to mechanical stress 
factors such as pressure, hypoxic or ischemic stress. The presence of a gastric band could 
probably cause a higher mechanical pressure and hypoxia than the torsion of abomasum itself. 
It should also be considered that these results come only from 3 cows. Compared to the 
healthy cows, a significant decrease in the amount of motilin receptors and an increase in the 
amount of VIP receptors in cows with abomasal displacement is most probably a consequence 
of the abomasal displacement itself.  
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6.3 Conclusions 
 
The results from recent studies indicate that the neurotransmitters and gastrointestinal 
peptides could play a role in the occurrence of AD. Varying densities of motilin receptors, 
muscarinic, and adrenergic receptors were found in the abomasal and duodenal wall of cows 
with AD in comparison to healthy cows (Ontsouka et al. 2007, 2010). Sickinger (2007) 
performed an inter- and intra-breed analysis regarding substance P and vasoactive intestinal 
polypeptide densities in the abomasal wall of German Holstein and German Fleckvieh cows. 
This study showed for the first time that the stimulating factor substance P is lower in GH 
cows than in GFV cows.  
 
The lower amounts of motilin receptors in the abomasal wall of GH cows found in this study 
could be a factor why GH cows are more prone to AD than GFV cows. However, the 
difference between these two breeds is not significant. Other gastrointestinal neuropeptides or 
hormone disturbances could also play a role in this disorder. This result coincides with the 
results from Sickinger (2007), who suggested that a lower amount of the motility stimulating 
factor SP in GH cows might be responsible for the more frequently occurring AD in this 
breed, compared to GFV cows. Assumably, stimulating factors play a more important role in 
this inter-breed difference between GH and GFV cows, compared to inhibiting factors. 
  
Concerning the intra-breed comparison, the abomasal wall of GH cows with AD has a 
significantly lower density of motilin receptors, accompanied by an increased number of 
VPAC1 receptors, compared to healthy GH cows. This could be the cause of the 
predisposition for the occurrence of AD. Furthermore, a significant increase in apoptotic cells 
is found in the abomasal wall of GH cows with AD in comparison to healthy GH cows. This 
result could explain the decrease in the amount of motilin receptors in cows with AD. It is 
also possible that, an increase in apoptotic cells in the abomasal wall of cows with AD not 
only affects the amount of motilin receptors, but also hormones, neuropeptides, cell walls, and 
neuronal structures, which suggests the involvement of other possible factors and substances 
in the occurrence of AD. 
  
The findings of this study indicate that the differences in the amounts of motility inhibiting 
and stimulating factors are a consequence of the abomasal displacement itself, rather than 
being a cause of it.  
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7 Summary 
 
Objective 
The aim of this study was to examine the possible effects of gastrin, motilin peptides, their 
receptors and vasoactive intestinal polypeptide (VIP) receptors on the occurrence of abomasal 
displacement (AD). A decreased amount of stimulating factors (motilin, motilin receptors) 
accompanied by an increased amount of inhibiting factors (gastrin, gastrin receptors, VIP 
receptors) in the abomasal wall could be a cause of the hypo- or atony of the abomasum prior 
to the abomasal displacement. The caspase-3 activity of the abomasal wall was also examined 
as apoptosis marker in order to investigate the degree of impairment of the abomasal wall 
between healthy cows and cows with AD.   
 
Material and methods 
Biopsies of the corpus abomasi and antrum pylori were available from 20 slaughtered German 
Holstein cows and from 20 German Fleckvieh cows. Furthermore, material from 20 other 
German Holstein cows with abomasal displacement as well as biopsies from another three 
cows of this breed were available. In the latter, an abomasal impaction was experimentally 
induced by placing a variable gastric band. The paraffin embedded biopsy samples were cut 
6µm thick with a microtome for the immunohistochemical investigations. The positive signals 
were quantified by measuring the stained areas using semiautomatic software program 
AnalySIS® (Olympus). In this study gastrin and motilin peptides, their receptors, VIP 
receptors and caspase-3 were stained immunohistochemically (ABC-/AEC-technique). 
 
Results 
Gastrin was detected only in the tunica mucosa of the antrum. No significant breed difference 
was found between German Holstein (GH) and German Fleckvieh (GFV) regarding the 
immunoreactive (IR) area of this gastrointestinal peptide (GFV: 1174 ± 655 µm², GH: 1105 ± 
930 µm²). The comparison between GH with abomasal displacement (AD) and without AD, 
GH cows with AD revealed a larger IR gastrin area (GH with AD: 1277 + 863 µm²). 
However, this difference was not significant.  
 
Gastrin receptors (CCKBR) were detected neither in GH nor in GFV cows in the tunica 
muscularis of the abomasal wall.  
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Motilin also could not be detected in any layer of the abomasal wall of both breeds contrary to 
the motilin receptors. In both localizations of the abomasal wall of GFV cows, the IR area for 
these receptors tended to be larger than in GH cows without AD (antrum: 206 ± 57 µm² vs. 
179 ± 53 µm²; corpus: 172 ± 69 vs. 152 ± 52 µm²). No significant differences were found in 
this regard (p = 0.11).  
 
The intra-breed comparison observed significant larger motilin receptor IR areas in GH cows 
without AD compared to GH cows with AD in both localizations (antrum: 125 ± 55 µm²; 
corpus: 124 ± 43 µm²; p = 0.003). In GH cows with experimentally induced abomasal 
impaction, a decrease of the IR area of motilin receptors was detected after placing the gastric 
band for 72 hours (antrum, 1st OP: 95 ± 46 µm², 2nd OP: 47 ± 8 µm²; corpus, 1st OP: 101 ± 
19 µm²; 2nd OP: 80 ± 28 µm²), however this decrease was not significant (p = 0.27).  
 
Regarding the number of VPAC1 receptor in the abomasal wall, no inter-breed difference 
could be detected (antrum: GFV 19 ± 10, GH 18 ± 6; corpus: GFV 19 ± 10, GH 18 ± 8). 
However, GH cows with AD have a significant higher number of these receptors compared to 
the healthy cows of this breed (GH with AD antrum: 24 ± 11, corpus: 26 ± 11; p = 0.005). It 
is also observed that, experimental induction of an abomasal impaction has also increased the 
number of VPAC1 receptors (antrum, 1st OP: 13 ± 5, 2nd OP: 15 ± 4; corpus, 1st OP: 16 ± 6,   
2nd OP: 20 ± 10), however this difference was not significant.  
 
Caspase activity, as a criterion for the impairment of the abomasal wall, was significantly 
higher in GH cows with abomasal displacement compared to healthy GH cows (GH cows 
with AD antrum: 26 ± 11%, corpus: 29 ± 9%, GH cows without AD antrum: 17 ± 6%, corpus: 
21 ± 7%, p = 0.002). The same tendency was also observed in GH cows with experimentally 
induced AD, however this difference was not significant (p = 0.12). Also no significant 
difference was detected in the ratio of apoptotic cells between both breeds.  
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Conclusions 
The motilin receptor seems to have an important role in the abomasal motility. Motilin 
receptors are detected in the tunica muscularis of abomasal wall of all subjects. The tendency 
that GFV cows have higher amounts of motilin receptors in their abomasal wall, might 
explain why the cows of this breed are less susceptible to AD. The reduced amounts of 
motilin receptors in the GH cows with AD and experimentally induced abomasal impaction, 
in comparison to the healthy GH cows, indicates that AD could cause mechanical destruction 
of these receptors due to the mechanical stretching or hypoxia of the abomasal wall, to which 
the increase of the caspase activity could provide evidence. 
Gastrin seems not to be involved in the occurrence of AD. The absence of the gastrin 
receptors in the abomasal wall found in this study supports this finding. 
A lower amount of motilin receptors and a higher amount of VPAC1 receptors in GH cows 
with AD, compared to healthy GH cows, could be an explanation for the occurrence of AD in 
these cows. However, according to the results gathered from the subjects with artificially 
induced abomasal impaction indicates that these changes were likely a consequence of AD 
itself, rather than being a cause of it.  
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8 Zusammenfassung 
 
Zielsetzung der Studie 
Das Ziel dieser Studie war es, die Bedeutung von Gastrin und Motilin, sowie deren 
Rezeptoren und Vasoaktives-Intestinales-Polypeptid Rezeptoren beim Auftreten von 
Labmagenverlagerungen (LMV) zu untersuchen. Eine reduzierte Zahl stimulierender 
Faktoren und eine erhöhte Zahl inhibitorischer Faktoren in der Labmagenwand könnte eine 
Ursache für die Hypo- oder Atonie des Labmagens vor einer LMV sein. Caspase 3 -als 
Apoptose-Marker- wurde zur Einschätzung des Schädigungsgrades der Labmagenwand 
bestimmt und zwischen den gesunden Kühen und solchen mit LMV verglichen.   
 
Material und Methode 
Zur Untersuchung standen Gewebeproben von jeweils 20 gesunden Kühen der Rassen 
Deutsches Fleckvieh und Deutsche Holsteins zur Verfügung. Ebenso konnte auf Material von 
20 Deutschen Holstein-Kühen mit Labmagenverlagerung sowie auf Gewebeproben von drei 
weiteren Kühen dieser Rasse zurückgegriffen werden, bei denen experimentell – durch 
Anlegen eines Magenbandes - eine Labmagendilatation induziert wurde. Die in Paraffin 
eingebetteten Gewebeproben wurden für die immunhistologischen Untersuchungen in 6 µm 
dicke Schnitte aufgearbeitet. Die dargestellten Peptide wurden quantifiziert, indem die 
angefärbten Flächen und Zellen unter Verwendung des halbautomatischen 
Softwareprogramms AnalySIS® (Olympus) ausgemessen wurden. Berücksichtigt wurden in 
dieser Studie die Peptide Gastrin und Motilin und deren Rezeptoren sowie zusätzlich der 
Vasoaktives Intestinales Polypeptid Rezeptor-1 (VIPR1) und die Caspase Aktivität. Für die 
immunhistochemischen Untersuchungen kam ein indirektes Verfahren mit der ABC-/ AEC-
Methode zur Anwendung. 
 
Ergebnisse 
Gastrin konnte nur in der Mukosa des Antrumbereichs dargestellt werden. Bezüglich der 
immunreaktiven Fläche für diesen Neurotransmitter ergab sich kein signifikanter Unterschied 
zwischen den Rassen Deutsches Fleckvieh (DFV) und Deutsche Holsteins (DH)              
(DFV: 1174 ± 655 µm², DH: 1105 ± 930 µm²). Im Vergleich zwischen Deutschen Holsteins 
mit Labmagenverlagerung (LMV) und solchen ohne diese Erkrankung hatten erstere eine 
größere IR-Gastrin-Fläche (DH mit LMV 1277 ± 863 µm²). Dieser Unterschied war 
allerdings nicht signifikant.  
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Gastrin-Rezeptoren (CCKBR) konnten weder beim DFV noch bei den DH in der glatten 
Muskulatur der Labmagenwand nachgewiesen werden. 
Motilin konnte bei keiner Kuh in irgendeinem Bereich des Labmagens dargestellt werden – 
im Gegensatz zu den Motilin-Rezeptoren. Hierbei erwies sich die IR-Fläche für diese 
Rezeptoren bei den DFV-Kühen in beiden Lokalisationen des Labmagens tendenziell größer 
als bei den Deutschen Holsteins ohne LMV (Antrum: 206 ± 57 µm² vs. 179 ± 53 µm²; 
Corpus: 172 ± 69 vs. 152 ± 52 µm²); signifikante Unterschiede konnten diesbezüglich jedoch 
nicht nachgewiesen werden (p = 0,11).  
Innerhalb der Rasse Deutsche Holsteins hatten Kühe ohne LMV an beiden Lokalisationen 
eine signifikant größere IR-Fläche an Motilin-Rezeptoren, als dies bei den Tieren mit LMV 
der Fall war (Antrum: 125 ± 55 µm²; Corpus: 124 ± 43 µm²; p = 0,003). Bei den drei DH-
Versuchskühen mit experimentell induzierter Labmagendilatation kam es in Zusammenhang 
mit der Dehnung der Labmagenwand innerhalb von 72 Stunden zu einer Abnahme der IR-
Flächen für die Motilin-Rezeptoren (Antrum, 1. OP: 95 ± 46 µm², 2. OP: 47 ± 8 µm²; Corpus, 
1. OP: 101 ± 19 µm²; 2.OP: 80 ± 28 µm²). Allerdings war dieser Unterschied nicht signifikant 
(p = 0,27). 
Bezüglich der Anzahl der VIP1-Rezeptoren in der Labmagenwand ergaben sich keine  
Rassenunterschiede (Antrum: DFV 19 ± 10, DH 18 ± 6; Corpus: DFV 19 ± 10, DH 18 ± 8). 
Allerdings lag bei den DH-Kühen mit LMV deren Anzahl – im Vergleich zu den gesunden 
Probanden dieser Rasse, signifikant höher (DH mit LMV Antrum: 24 ± 11 Corpus: 26 ± 11;  
p = 0,005). 
Es war auch festzustellen, dass die experimentelle Induktion einer Labmagenanschoppung mit 
einem Anstieg der Anzahl an VIP-Rezeptoren verbunden war (Antrum, 1. OP: 13 ± 5, 2. OP: 
15 ± 4, Corpus, 1. OP: 16 ± 6, 2. OP: 20 ± 10). Allerdings war dieser Unterschied nicht 
signifikant. 
Die Caspase-Aktivität, als Kriterium einer Schädigung der Labmagenwand, war bei den 
Kühen mit Labmagenverlagerung - im Vergleich zu den gesunden Kontrollkühen – 
signifikant erhöht (DH ohne LMV Antrum: 17 ± 6 %, Corpus: 21 ± 7 %; DH mit LMV 
Antrum: 26 ± 11 %, Corpus: 29 ± 9 %; p = 0,002). Bezüglich des  Rassenvergleiches ergab 
sich kein signifikanter Unterschied zwischen den Rassen Deutsches Fleckvieh und Deutsche 
Holsteins. 
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Schlussfolgerungen 
Dem Motilin-Rezeptor scheint bei der Motilität des Labmagens eine wichtige Bedeutung 
zuzukommen. So konnten auch in diesen Untersuchungen in allen Proben Motilin-Rezeptoren 
in der Labmagenwand nachgewiesen werden. Die tendenziell größere Dichte an Motilin-
Rezeptoren bei den DFV-Kühen könnte erklären, warum Kühe dieser Rasse weniger häufig 
an Labmagenverlagerung erkranken. Die bei den Holstein-Kühen mit Labmagenverlagerung 
bzw. mit induzierter Labmagenanschoppung – im Vergleich zu den gesunden Probanden 
dieser Rasse - nochmals reduzierte Zahl an Motilin-Rezeptoren dürfte auf eine mechanische 
Zerstörung dieser Rezeptoren im Zuge des Krankheitsgeschehens zurückzuführen sein, wozu 
die Erhöhung der Caspase-Aktivität einen Hinweis liefern könnte. 
Gastrin scheint keinen direkten Effekt auf die Labmagenverlagerung zu haben. Die 
Abwesenheit der Gastrin-Rezeptoren in der Labmagenwand ist im Einklang mit diesem 
Ergebnis. 
Eine reduzierte Zahl an Motilin-Rezeptoren und erhöhte Zahl an VIP1-Rezeptoren bei den 
Holstein-Kühen mit LMV - im Vergleich zu den gesunden Probanden dieser Rasse könnte 
eine Erklärung für das Auftreten einer Labmagenverlagerung liefern. Die Ergebnisse der 
Untersuchungen an Probanden mit einer expeimentell induzierten Labmagenanschoppung 
deuten jedoch darauf hin, dass es sich bei den ermittelten Unterschieden zwischen gesunden 
Holstein-Kühen und solchen mit einer Labmagenverlagerung eher um eine Folge der 
Verlagerung als um deren Ursache handelt. 
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Appendices 
 
 
Used chemicals and tools 
 
 Vector Vectastatin ABC-Elite-Kit PK-6100 Standard, Vector Laboratories USA 
 Peroxidase substrate AEC-Kit, product no. AE002, Biologo Dr. H. Schultheiß e. K., 
Kronshagen 
 Methanol for synthesis, 2.5 l, product no. 8.222283.2500, Merck Schuchardt OHG, 
Hohenbrunn 
 PBS tablets, product no. P4417-50/100TAB, Sigma Aldrich Chemie GmbH, 
Taufkirchen 
 Superfrost Plus microscopic slides, product no. 6776214, Thermo Fisher Scientific, 
Steingrund 
 Goat serum, product no. C-37651, Promocell GmbH, Heidelberg 
 Rabbit serum, product no. X090210-8, Dako Deutschland GmbH, Hamburg 
 Horse serum, product no. BA-2000, VectorLaboratories Inc., Burlingame, USA 
 Bovine serum albumin, albumin fraction V, product no. 8076.2, Carl Roth GmbH & 
Co. KG, Karlsruhe 
 Triton X-100 Detergent, product no. 648462, Calbiochem, EMD Biosciences, Merck, 
Darmstadt 
 Cover slips, 24 x 24 mm, Roth, Karlsruhe 
 Gelatine, product no. 1.09242.0100, Merck, Darmstadt 
 Hematoxylin, product no. 6765015, Anatomical Pathology Pittsburgh, USA 
 Aqua dest 
 Xylol, product no. UN 1307, Stockmeier Chemie Dillenburg GmbH & CoKG, 
Dillenburg 
 Ethanol, product no. UN 1170, Stockmeier Chemie Dillenburg GmbH & CoKG, 
Dillenburg 
 Microtome, HM 400 Microm, Leica Instruments GmbH, Nussloch 
 Magnetic stir/hot plate, Heidolph MR 3001, MAGV Laborbedarf, Rabenau-Londorf 
 Wacom intuos® 3 graphics tablet, Wacom Europe GmbH, Krefeld 
 AnalySIS Pro 3.2 software; Soft Imaging System GmbH; Olympus Soft Imaging 
Solutions GmbH, Münster 
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Formulation for solutions and buffers 
 
Citrat buffer: 
Solution A:  0,1 m citric acid 
  4,2 g C6H8O7 x H20 in 200 ml aqua dest. 
 
Solution B:  0.1 m sodium citrate 
  29,41 g C6H5O7Na3 x 2 H2O 
 
Usage:  7 ml solution A + 41 ml solution B + 452 ml aqua dest. 
After mixing aqua dest and solution B, the pH of the buffer will be adjested to 6.0 
using solution A  
 
Blocking buffer:  
21 µl triton X 
1g BSA  
Dissolve in 70 ml PBS 
 
0,3 % H2O2 in icecold methanol: 
0,5 ml 30 % H2O2     
49,5 ml methanol (icecold) 
 
PBS solution 
1 Sigma Aldrich P 4417 PBS tablet + 200 ml aqua dest. 
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Table 9: Data for statistical analysis  
 
  
 
 
 
 
 
1= with OP GH
2= without OP GH 1=Antrum 2=Corpus
3= without OP GFV
Localisation
Groups Animal No
Ga1 MR1 VIPR1 Casp1 Ga2 MR2 VIPR2 Casp2
1 1 2573,18422 117,039914 43 9,17 157,773999 36 7,5
1 2 1276,14644 171,809109 28 12,41 154,305552 33 15,2
1 3 1598,47001 119,338769 29 15,07 106,473251 41 17,41
1 4 1586,57243 213,470802 13 15,15 199,35503 12 20,17
1 5 1930,75528 43,5169082 14 19,27 202,863807 22 24,67
1 6 1726,80254 60,2541806 20 20,08 58,3586341 24 26,16
1 7 1042,8329 190,562921 13 20,56 181,085188 43 26,16
1 8 556,282405 145,836089 12 20,72 126,557978 42 26,7
1 9 199,153376 89,6956477 21 20,91 67,9170282 22 27,09
1 10 56,382426 153,055298 37 22,73 94,5353409 21 28,04
1 11 1933,41711 91,3895403 52 24,5 110,06269 29 30,71
1 12 118,693476 174,591933 17 24,94 112,724521 16 31,94
1 13 1187,91694 181,004526 20 26,4 104,255058 24 32,66
1 14 1252,55294 133,252887 36 30,05 153,781252 47 36,38
1 15 2174,23218 60,6574883 14 31,51 126,759632 23 36,93
1 16 3013,27366 58,9635957 10 39,48 89,453663 8 37,45
1 17 2018,23273 162,734684 16 39,53 161,242446 25 37,5
1 18 509,861681 190,441928 17 41,23 119,137115 12 39,89
1 19 148,538251 37,6286148 28 41,88 77,5157531 19 42,25
1 20 636,50032 99,8590034 34 44,84 68,9656284 22 42,67
2 3 924,66372 119,016122 24 6,86 192,61979 38 6,88
2 4 719,339735 170,437863 25 7,79 105,787628 17 12,75
2 12 1365,27746 129,865101 9 8,03 149,707844 12 14
2 13 975,440168 144,989143 12 10,1 186,570174 22 14,83
2 14 1619,0387 159,951861 14 11,42 150,393467 13 15,81
2 18 1839,04309 187,618774 24 13,72 164,146262 15 16,4
2 19 1810,4889 219,197772 17 13,78 257,068371 32 20,02
2 20 2390,98574 279,859944 15 15,79 238,395222 31 20,57
2 23 172,777048 135,108102 8 17,72 112,966506 20 21,51
2 24 2720,47222 152,12769 14 17,82 94,4546793 20 21,81
2 25 562,009375 145,271458 17 18,79 98,2457723 14 22,4
2 27 1411,29487 148,417259 8 18,9 132,204286 11 22,4
2 28 2831,34153 196,24956 21 18,98 120,831007 19 23,23
2 29 521,476944 135,269426 20 19,59 131,518663 8 24,68
2 31 200,484292 134,180494 29 20,02 189,554651 22 24,74
2 32 1891,67833 195,442944 21 20,72 227,344589 18 25,1
2 43 24,8034278 158,943591 25 23 75,4185527 13 28,47
2 44 119,94373 285,985538 22 24,23 139,181511 11 30,37
2 48 0 288,728031 8 25,02 180,480226 12 30,86
2 50 0 191,127551 12 25,26 88,2437397 8 31,9
3 6 1030,69333 189,99829 23 5,82 166,324124 35 8,74
3 9 751,322041 315,346344 25 6,08 269,893559 26 9,47
3 10 1514,461 120,064723 9 7,88 142,24665 9 14,41
3 11 639,968767 199,113045 7 8,77 144,766803 7 15,05
3 15 915,387642 195,805921 29 11,5 98,0037877 33 15,09
3 17 1015,28698 272,353736 28 11,86 135,471079 28 15,2
3 21 752,047995 265,457173 24 14,6 125,025408 29 15,7
3 22 1704,94326 176,568141 6 14,95 139,947796 9 16,68
3 26 915,21697 122,202254 5 16,44 187,780097 4 18,26
3 33 2581,85534 201,532892 25 16,91 82,7990848 33 19,29
3 34 1295,2229 214,96304 10 18,63 256,745725 27 20,84
3 37 2142,04822 287,155131 6 20,91 148,175274 28 21,4
3 38 782,497732 202,581492 30 21,45 97,5601491 20 24,28
3 39 1121,88122 255,737456 7 23,96 155,031506 3 24,86
3 40 1704,70127 202,662154 27 24,1 112,11956 22 26,02
3 41 971,205437 226,578304 26 24,97 349,829158 26 26,85
3 42 1766,4007 134,140164 32 28,35 271,345466 8 27,49
3 46 1860,49565 101,714219 29 28,43 179,512288 10 28,92
3 52 25,6503741 216,132633 13 31,41 147,167005 20 34,05
3 54 0,1 218,875126 19 32,2 222,948534 7 38,97
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Table 10: Data for statistical analysis including animals with gastric band operation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data for statistical analysis 1=Antrum
Gastric band 2=Corpus
1 2
Groups
1= Gastric band OP1 Ga1 MR1 VIPR1 Casp1 Ga2 MR2 VIPR2 Casp2
2= Gastric band OP2 1 MB1OP1 288,728031 124,823754 9 25,74 101,996535 13 12,39
3= GH with OP 1 MB2OP1 10,848979 42,1859926 12 20,77 81,3471769 22 28,94
4= GH without OP 1 MB3OP1 333,091886 118,693476 19 11,43 119,056453 12 12,45
2 MB1OP2 245,735423 58,4796264 16 43,91 39,3628382 30 39,65
2 MB2OP2 252,067355 43,0732697 12 27,14 101,028596 12 33,02
Abbreviations 2 MB3OP2 383,626349 39,2418459 18 23,16 99,9799958 17 24,1
Ga = Gastrin 3 OP1 2573,18422 117,039914 43 30,05 157,773999 36 17,41
MR = Motilin receptor 3 OP2 1276,14644 171,809109 28 20,91 154,305552 33 26,16
VIPR= Vip receptor 1 3 OP3 1598,47001 119,338769 29 20,08 106,473251 41 42,67
Casp = Caspase-3 3 OP4 1586,57243 213,470802 13 39,48 199,35503 12 20,17
MB = Gastric band 3 OP5 1930,75528 43,5169082 14 41,88 202,863807 22 27,09
3 OP6 1726,80254 60,2541806 20 9,17 58,3586341 24 15,2
3 OP7 1042,8329 190,562921 13 24,5 181,085188 43 30,71
3 OP8 556,282405 145,836089 12 20,56 126,557978 42 24,67
3 OP9 199,153376 89,6956477 21 26,4 67,9170282 22 28,04
3 OP10 56,382426 153,055298 37 39,53 94,5353409 21 37,45
3 OP11 1933,41711 91,3895403 52 15,15 110,06269 29 7,5
3 OP12 118,693476 174,591933 17 22,73 112,724521 16 32,66
3 OP13 1187,91694 181,004526 20 12,41 104,255058 24 36,38
3 OP14 1252,55294 133,252887 36 44,84 153,781252 47 31,94
3 OP15 2174,23218 60,6574883 14 15,07 126,759632 23 26,16
3 OP16 3013,27366 58,9635957 10 24,94 89,453663 8 26,7
3 OP17 2018,23273 162,734684 16 31,51 161,242446 25 36,93
3 OP18 509,861681 190,441928 17 41,23 119,137115 12 42,25
3 OP19 148,538251 37,6286148 28 19,27 77,5157531 19 39,89
3 OP20 636,50032 99,8590034 34 20,72 68,9656284 22 37,5
4 3 924,66372 119,016122 24 18,9 192,61979 38 14,83
4 4 719,339735 170,437863 25 18,98 105,787628 17 16,4
4 12 1365,27746 129,865101 9 24,23 149,707844 12 22,4
4 13 975,440168 144,989143 12 6,87 186,570174 22 20,57
4 14 1619,0387 159,951861 14 25,26 150,393467 13 15,81
4 18 1839,04309 187,618774 24 17,82 164,146262 15 20,02
4 19 1810,4889 219,197772 17 13,72 257,068371 32 21,51
4 20 2390,98574 279,859944 15 8,03 238,395222 31 6,88
4 23 172,777048 135,108102 8 23 112,966506 20 22,4
4 24 2720,47222 152,12769 14 11,42 94,4546793 20 30,37
4 25 562,009375 145,271458 17 20,02 98,2457723 14 24,68
4 27 1411,29487 148,417259 8 13,78 132,204286 11 14
4 28 2831,34153 196,24956 21 7,79 120,831007 19 23,23
4 29 521,476944 135,269426 20 10,1 131,518663 8 21,81
4 31 200,484292 134,180494 29 15,79 189,554651 22 12,75
4 32 1891,67833 195,442944 21 25,02 227,344589 18 28,47
4 43 24,8034278 158,943591 25 20,72 75,4185527 13 30,86
4 44 119,94373 285,985538 22 19,59 139,181511 11 25,1
4 48 0 288,728031 8 18,79 180,480226 12 31,9
4 50 0 191,127551 12 17,72 88,2437397 8 24,74
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